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SUMMARY 
myo-Inositol-1,2,3,4,5,6-hexakisphosphate (InsP6), also called phytic acid, is 
ubiquitous in eukaryotic cells and the most abundant inositol phosphate derivative.  
Loblolly pine (LP, Pinus taeda) constitutes the primary commercial species in the 
southern forest of U.S.  Somatic embryogenesis (SE) is an effective technique to 
maintain the desirable genetic composition of the progeny and to accomplish the 
efficiency of propagation.  SE can also serve as a tool for study of plant development.  
Unlike angiosperm embryos with attached cotyledons as seed storage organs, the 
diploid conifer embryo is surrounded by the unattached haploid female gametophyte 
(FG).  In LP SE, FG tissue is absent in the embryogenic tissue culture.  We found that 
extracts from early-stage FG stimulate growth and multiplication of early-stage 
somatic embryos, whereas FG water extracts from late stage contain substance(s) 
inhibitory to early-stage somatic embryo growth (DeSilva et al., 2007).  We now 
present the isolation and identification of the inhibitory substance as InsP6 by means 
of water extraction, two gel filtrations and two ion exchange FPLC chromatographies.  
The results represent the first complete structural characterization of InsP6 from a 
natural product using LC/MS, LC/MS/MS, exact MS, 1D- and 2D-NMR analyses.  
We also report that there is a good correlation between the amount of InsP6 purified 
from FG tissue (1.3 nmoles per full-term FG) and the amount of InsP6 which inhibits 
somatic embryo growth.  This novel approach of isolating and characterizing InsP6 
from plant tissue, and investigating its role on SE can allow us to improve SE 
technology by circumventing current bottleneck, to elucidate enigmatic functions of 
InsP6 in plants, and most importantly, to utilize this molecule properly.
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CHAPTER I 
 
INTRODUCTION 
 
Somatic Embryogenesis 
Importance and History of Somatic Embryogenesis 
With the growing demand for wood products all over the world, an increasing 
need for production of high-value tree species is becoming more and more prominent. 
Innovative technology for the generation of new hybrids, early selection and testing of 
desirable genotypes, rapid vegetative propagation of selected genotypes needs to be 
developed to meet the rapidly growing demand.  Among all the tree improvement 
programs, there are two basic factors to determine its success: the quality of the product 
and the economy of propagation.  Vegetative propagation is superior to sexual 
reproduction in that it can not only maintain the desirable genetic composition of the 
progeny, but also accomplish the efficiency of propagation.  
The commercial applications of cell and tissue culture to mass propagation enable 
the growth of tissue or organ segments in proper media which allow their development 
through one specific pathway.  The most common pathway, known as 
“micropropagation”, involves the regeneration of whole plants or multiple shoots from 
stem segments or from excised shoot apices.  Another pathway, known as “somatic 
embryogenesis (SE)”, which is also the most promising and desirable so far, is to 
reproduce whole plants from callus and suspension cultures (Jain et al., 1995).  Well 
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controlled SE is not only able to maintain the genetic stability and assure juvenile plants 
of normal growth habit, but also liable to mass production and planting. 
Zygotic embryos resulting from gametic fusion are structurally observed bipolar 
with root and shoot on opposite ends.  Somatic embryos or embryoids are “embryo-like” 
structures in tissue cultures of various plant species.  The formation and development of 
somatic embryos is termed “somatic or asexual embryogenesis” (Jain et al., 1995).   
The idea of SE first started with the regeneration of adventitious buds from 
cambial tissue of Ulmus campetris (Gautheret, 1940).  In this work, some root was 
formed, but complete plantlets were not generated. Winton (Winton, 1970) reported the 
first regeneration of complete plants from tissue culture from leaf explants of aspen.  Due 
to the discovery of cytokinins, explant sources were managed to be cultured in vitro for 
callus and plantlet production.  Since Sommer and Wetzstin published more than 100 
species of angiospermic woody plants reproduction from zygotic embryos and/or young 
seedlings in 1984 (Sommer and Wetzstein, 1984), the number of hardwood species able 
to reproduce in vitro has almost doubled. 
Sharp (Sharp et al., 1982) differentiated two patterns of the origin of somatic 
embryos from in vitro grown explants:  
a. Pro-embryonic-determined cells (PEDC), somatic embryos originate from explant 
cells in which only an in vitro environment is needed to be released from some 
suppressive condition.  Examples of PEDC in woody angiosperms include Citrus, 
Ilex aquifolium, Malus domestica, Mangifera indica, Theobroma cacao, and Pyrus 
spp. 
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b. Induced embryogenic-determined cells (IEDC), also known as indirect production of 
somatic embryos from an unorganized callus/tissue mass.  In this case, a series of 
growth regulators are needed to first form callus, then to reproduce somatic embryos.  
IEDC requires the release of previously differentiated state through mitotic cell 
divisions, and an induction of the new pattern of cell divisions to form organized 
embryos.  Examples of IEDC span both monocots and dicots including Cocos 
nucifera, Chamedorea costaricana, Phoenix dactylifera, Elaeis guineensis, Coffea 
Arabica, Pyrus communis, Santalum album.  Although plants follow either pattern of 
somatic embryo development, they are not mutually exclusive.   
The commercial plantation of SE was first presented by Blake for oil palms 
(Blake, 1983).  A major problem for most commercial somatic embryos since then was 
the low frequency of maturation and germination into whole plants.  Various attempts 
were made to improve both the quality and yield of mature somatic embryos to germinate 
in multiple species of Picea (Roberts et al., 1993).  Von Arnold and Hakman (von Arnold 
and Hakman, 1988) demonstrated that light can inhibit the germination of somatic 
embryos.   
The use of large-scale bioreactors in liquid cultures has proved to be the ideal 
approach to increasing the efficiency of SE in gymnosperms, including Picea abies, 
Picea mariana, Pinus caribaea, Pinus strobus, etc.  Additionally, Chen and Kartha 
reported that cryopreservation was ideal for maintaining superior genotypes in an 
embryogenic state for a long period (Chen and K.K., 1987). 
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Somatic embryogenesis in vivo and in vitro 
Natural asexual embryos were reported in several angiosperm families.  Although 
other tissues including integuments, synergids and embryo-suspensors are able to 
generate asexual embryos, they originate predominantly from the nucellus.  Therefore, 
seeds contain multiple embryos in addition to the zygotic embryo.  This phenomenon is 
called “polyembryony”.  There are two possibilities that cause polyembryony in conifers: 
A) sperm nuclei contained in one or more pollen tubes fertilize more than one 
archegonium or egg cell 
B) the cleavage of the embryonal segments of one or more zygotic embryos 
The natural occurrence of “cleavage polyembryony” in vivo inspired the idea of 
somatic embryogenesis in conifers, since four genera of the Pinaceae family, including 
Pinus, Cedrus, Keteleeria and Tsuga, show cleavage polyembryony (Jain et al., 1995).  
Four major steps involved in the process of SE in culture were summarized as following: 
A) Initiation or induction of somatic embryos from primary explants which could 
be female or megagemetophytes without embryos, female gametophytes with 
intact zygotic embryos, precotyledonary zygotic embryos, cotyledonary 
embryos from fresh seed cones and stored dry seeds, seedling explants.  
B) Multiplication or proliferation of embryogenic cultures.  After the initiation of 
embryogenic tissue occurs, the tissue needs to be mainteined on fresh media 
gelled or in liquid suspension cultures to sustain proliferation.  
C) Development and maturation of somatic embryos, which includes free nuclear 
somatic proembryo phase, cellular somatic proembryo phase, precotyledonary 
somatic embryo phase and cotyledonary somatic embryo phase. 
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D) Germination in which plantlets exhibit a well formed root, an elongated 
hypocotyl and cotyledons. 
 
Importance of LP 
The pine (Pinaceae) family belongs to the Pinales order of gymnosperms which 
are a group of vascular plants whose seeds are not enclosed by a ripened ovary (fruit) 
(Mirov, 1967).  Loblolly pine (LP, Pinus taeda), a species of pine family, constitutes the 
primary commercial species in the southern forest of U.S. covering 13.4 million ha., 
approximately 45% of commercial forestland.  Over 1.5 billion loblolly pine seedlings 
are planted in U.S. each year (Schultz, 1999).  In the southern U.S., one of nine 
manufacturing jobs can be linked to southern pine forests, from planting to the production 
of forest-based products.   
 
Somatic embryogenesis in Loblolly Pine 
Implementation of clonal tree production is a major trend for the forest industry.  
For many softwood trees including LP, SE is the most promising method to overcome 
both economic barriers (investments vs. returns) and biological barriers (Timmis, 1998).  
The successful development of SE will allow superior, faster-growth LP trees to be 
replicated in large-scale, commercial numbers for replanting initiatives, which will in 
turn benefit our society and economy by conserving national forestland, sequestering 
carbon dioxide and revitalizing the U.S. forest products industry.  In addition to its 
practical application, SE can serve as a tool for study of plant development (Zimmerman, 
1993).     
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SE in LP is also comprised of four major steps initiation, maintenance and 
multiplication, maturation and germination (Figure 1).  In initiation, zygotic seed 
embryos are used to initiate a culture in which cleavage polyembryony continues to form 
masses of early-stage somatic embryos through the application of plant hormones.  The 
numbers of the resulting somatic embryos are increased by transferring to a gelled or 
liquid multiplication medium, which contains plant hormones to continue cleavage 
polyembryony and somatic embryo multiplication.  Cultures may replicate 2-6 times 
weekly, rapidly producing large numbers of somatic embryos.  After a sufficient 
population of somatic embryos is obtained, embryos are placed on a development and 
maturation medium, in which a different set of plant hormones and environment 
conditions are provided.  During this step, somatic embryos continue their growth to a 
maxium of stage 9.1 compared to zygotic embryos that complete development with 
another 7-10 weeks of growth (stage 9.7-9.10).  In the last step, germination, somatic 
embryos are taken out of the tissue culture to produce somatic seedlings ready for 
planting in the field.  Our most advanced LP somatic embryos resemble stage 7-8 zygotic 
embryos in germination performance.   
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Figure 1.  Somatic embryogenesis in loblolly pine (Pullman et al., 2003a). 
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The failure of somatic embryos to fully mature is the bottleneck in the increased 
utilization of somatic seedlings.  Figure 2 shows an embryo staging system established by 
(Pullman and Webb, 1994), in which developmental stages of zygotic embryos of LP 
were determined by appearance, size, dry weight, germination ability and gene activity 
profiles (Cairney et al., 2000).  Figure 3 presents the corresponding staging system for 
somatic embryos of LP.  Zygotic embryos continue growth through stages 9.2-9.10 and 
acquire the ability to germinate at stage 7, whereas somatic embryos develop to a stage of 
8-9.1 vs. full development at 9.10.   Thus, only a low percentage of the most advanced 
genotypes of our LP somatic embryos are able to germinate and grow into seedlings.   
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Figure 2.  Zygotic embryos of loblolly pine, stages 1 through 9.2, modified from (Cairney 
and Pullman, 2007).  
  10
 
 
 
 
 
 
Figure 3.  Somatic Embryos of loblolly pine, Stages 1 through 9.1, modified from 
(Cairney and Pullman, 2007).
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Plant Polypeptide Hormones 
Peptide hormones are the most extensive signaling molecules in the animal 
kingdom, controlling cell interaction, differentiation and proliferation.  In contrast, in the 
world of plants, only five small organic compounds have traditionally been thought to 
regulate cell to cell communication.  The first of these five phytohormones are auxins, 
such as indole-3-acetic acid and 2,4-D; auxins stimulate cell elongation, cell division, and 
differentiation of phloem and xylem, and mediate gravitropic response, root initiation and 
root development (Mauseth, 1991; Raven, 1992; Salisbury and Ross, 1992; Davies, 1995).  
The second group is cytokinins, such as zeatin, whose structures resemble adenine.  
Cytokinins are involved in transportation of metabolites into plants and stimulation of 
cell division and morphogenesis (Mauseth, 1991; Raven, 1992; Salisbury and Ross, 1992; 
Davies, 1995; Kulaeva and Prokoptseva, 2004).  The third group is gibberellins that 
regulate seed and tuber dormancy release and transition to flowering in response to day 
length (Kulaeva and Prokoptseva, 2004).  The fourth group is abscisic acid, a 
sesquiterpenoid that induces and maintains dormancy in buds, tubers, bulbs and roots, 
and regulates the synthesis of storage proteins in seeds (Kulaeva and Prokoptseva, 2004).  
The fifth group is ethylene, which can induce defoliation, accelerate senescence and 
stimulate flower and fruit abscission (Kulaeva and Prokoptseva, 2004).  In addition to 
these five traditional groups, two other new classes of molecules brassinosteroids and 
jasmonates, have been counted as plant hormones as well.  The former group is 
polyhydroxylated steroid hormones mediating multiple physiological and developmental 
processes, including stem elongation, leaf expansion, xylem differentiation, seed 
germination, etc (Wang and He, 2004).  Jasmonates, which include jasmonic acid and its 
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cyclopentane derivatives, regulate root growth, fruit ripening, leaf abscission and 
senescence; they also mediate responses to stress, wounding, pathogen infection and UV 
damage (Shan et al., 2007). 
During the early 1990s, the discovery of systemin by Pearce et al. (1991) 
introduced us a new class of plant hormones, peptides, which changed the old idea that 
only small lipophilic compounds could serve as signaling molecules in plants.  This 18-
amino acid peptide was first discovered during the search for the systemic wound signal 
which induces the expression of defensive genes in response to wounding by predator 
attacks.  It activates the synthesis of protease inhibitors in young tomato plants at low 
nanomolar concentrations through their cut stems (Pearce et al., 1991).  The mature 
systemin is produced by proteolysis from a 200-amino acid precursor, called prosystemin 
(Pearce et al., 1991; McGurl et al., 1992).  Unlike animal peptide hormones, prosystemin 
lacks a signal sequence or any post-translational modifications, indicating that it is not 
processed through the secretory pathway (McGurl et al., 1992).  With the subsequent 
identification of homologs of the tomato prosystemin gene in other solanaceous species 
(Constabel et al., 1998) and the discovery of two hydroxyproline rich tobacco systemins 
(Pearce et al., 2001a), the systemin family has greatly expanded.  
Since the discovery of systemins, a number of additional peptides have been 
discovered that play a wide range of roles in the regulation of plant growth and 
development.  Among these are: phytosulfokine (PSK), which regulates callus formation 
and proliferation (Matsubayashi and Sakagami, 1996); SCR/SP11,  which is involved in 
self-incompatibility (Takayama and Isogai, 2005); CLV3, which plays an important role 
in regulating the growth of the shoot apical meristem (Brand et al., 2000; Trotochaud et 
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al., 2000); ENOD, which plays a central role in nodule development and symbiotic 
interaction (van de Sande et al., 1996); DVL and ROT 4,  which are critical to leaf 
morphogenesis (Narita et al., 2004; Wen et al., 2004); and IDA, which determines floral 
organ abscission (Butenko et al., 2003; Stenvik et al., 2006).  
Table 1 summarized 17 plant peptide hormones, containing identification and 
isolation, structures, functions, receptor and signaling pathway of these peptides.  Both 
PSK and CLV3 have been reported to promote SE, whereas RALF (Pearce et al., 2001b) 
can inhibit root growth and development in tomato.  All this information leads to the 
original proposal that plant peptide hormones absent from the SE culture might cause the 
maturation block in LP.   
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Plant Species Tissue Role/Function Peptide Isolation Peptide Isolation Protocol Bioassay
No. of 
a.a. Sequence
Molecular 
Weight (Da)
Precursor
(a.a.) Receptor Cofactor
Post-
translational 
modification
Family
tomato 
proline
-rich systemin 
(original)
Tomato, potato, 
pepper, and 
nightshade leaves
Defense signaling: triggers 
the production of jasmonic 
acid, which induces the 
production of defensive 
proteins
Y
DEAE cellulose
reversed-phase C18 flash chromatography
Sephadex G-25
strong  cation exchange chromatography
C18 reversed phase chromatography
 a. pH6  b. pH2.5
 strong cation exchange chromatography
C18 HPLC
Protease 
Inhibitor-
inducing Assay
18 1AVQSKPPSKRDPPKMQTD18 2010
200
no secretory 
pathway
SR 160
Mr: 160kD
(tomato plasma 
membrane)
No No
tobacco 
hydroxyproline
-rich systemin 
(TobHypSys I and 
II)
Tobacco 
leaves
Defense 
signaling Y
C18 reversed phase chromatography
Sephadex G-25
semi-preparative reversed-phase C18 chromatography
 cation exchange chromatography
narrow-bore reversed-phase chromatography
Alkalinization 
Assay 18
1RGANLPOOSOASSOOSKE18 
and 1NRKPLSOOSOKPADGQRP18
Tob 
Sys1:3060
Tob Sys2: 
2784
165
involved in the 
secretory 
pathway
N/D No
glycosylation, 
hydroxylation of 
prolines
tomato 
hydroxyproline
-rich glycopeptides
TomHypSys I, II 
and III 
Tomato leaves
Defense 
signaling Y
reversed-phase C18 flash chromatography
Sephadex G-25
semipreparative C18 reversed phase chromatography
strong cation exchange chromatography
analytical C18 reversed phase chromatography
narrow-bore C18 HPLC
Alkalinization 
Assay
18, 
20,
15
1RTOYKTOOOOTSSSOTHQ18
1GRHDYVASOOOOKPQDEQRQ20
1GRHDSVLPOOSOKTD15
2076
2530
1651
146 N/D No
glycosylation,  
hydroxylation of 
prolines
Arabidopsis leaves Defense signaling against pathogens Y
reversed-phase semipreparative C18 flash chromatography
Sepharose G-25
C18 reversed phase chromatography
ion exchange chromatography
narrow-bore HPLC
Alkalinization 
Assay 23
1ATKVKAKQRGKEKVSSGRPGQHN23 2491.7
At proPep1
92 aa
PEPR1
1124 aa, 
170 kD
No No N/D
asparagus,
rice,
zinnia,
carrot,
Arabidopsis
mesophyll promote cell division and development Y
DEAE Sephadex A-25 column
Bio-Gel P-2 extra fine column
Develosil ODS-HG-5 column
mitogenic 
activity
PSK-α: 5
PSK-β: 4
 PSK-α: H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln-OH
PSK-β: H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-OH
PSK-α: 846
OsPSK
89 aa
9.8 KD
post-
translational 
processing
PSKR
Mr: 120kD
(membrane 
fractions of 
carrot cells)
No sulfation of tyrosines N/D
legume species radicles of 
germinated seeds
stimulate cell proliferation
 and 
differentiation
Y an affinity column
a C18 reverse-phase column on HPLC
N/A 37
1ADCNGACSPFEVPPCRSR
DCRCVPIGLFVGFCIHPTG37
3925.6
pI 6.74
13045.9 Da
119 aa
43 kD
globulin, 
glycosylated
pI 9.05 to 9.26
N/D No N/D
Arabidopsis
floral 
abscission zone
deficient in 
floral abscission N N/A
mutation
 screening 77
1MAPCRTMMVLLCFVLFLAASSSCVA
AARIGATMEMKKNIKRLTFKNSHIFG
YLPKGVPIPPSAPSKRHNSFVNSLPH77
N/D
pI 11.87 N/D HAESA N/D N/D IDL
maize,
conserved in 
plants and animals
leaf epidermis
promotes multiple, 
actin-dependent cell
 polarization events
N N/A mutation screening 84
1MGRGGGMGNP VNVGIAVQAD WENRHFISN 
ISLNVRRLFD FLLRFEATTK SKLASLNEKLD 
ILERKLEVLE VQVGSATTNPSVFN84
8kD N/D
Scar/WAVE-
related plant 
ARP2/3 
activator 
proteins
N/D N/D N/D
Hedera helix
potato
Arabidopsis 
thaliana
 leaves
promote stomatal 
guard cell opening
maintein water and salt 
homeostasis
Y Sephadex G25-80Sepharose 4B immunoaffinity (ANP antisera)
stomatal 
opening
 bioassay
126
1MAVKFVVVMIVFAQILAPIAEAAQGKAVYY
DPPYTRSACYGTQRETLVVGVKNNLWQNGR
ACGRRYRVRCIGATYNFDRACTGRTVDVKV
VDFCREPCNGDLNLSRDAFRVIANTDAGNI
RVVYTP126
14016
pI 9.22 N/D N/D N/D N/D N/D
18 species, 
legume, non-
legumes, 
monocots and 
dicots, including
tobacco, maize, 
alfalfa, tomato and 
rice
cells surrounding 
vascular bundles,
low levels in 
stem and root cells 
rapidly growing 
tissues: meristems, 
fruits and ovules
 
induce root nodule 
organogenesis
N N/A N/A
Soybean:
12 aa
24 aa
Alfalfa:
13 aa
27 aa
Peptide A:  MELCWLTTIHGS
Peptide B:  MVLEEAWRERGVRGEGAHSSHSLT N/D N/D
soybean 
nodulin 
100
cytokinin No N/D
Systemin
BRICK
Plant Natriuretic
 Peptides
(PNP)
Name
Systemins
Leginsulin
At Pep1
Phytosulfokine
(PSK)
ENOD40
IDA
 
Table 1.  Summary of plant peptide hormones.  
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16 species, 
9 families
a variety of 
tissues including
 roots, shoots, 
leaves, flowers, 
ovules and 
ovaries
inhibit root growth and 
development in tomato 
and rabidopsis 
specific roles in growth 
unknown
Y
reversed-phase C18 flash chromatography
semipreparative reversedphase C18-HPLC
polySULFOETHYL Aspartamide column strong cation 
exchange-HPLC
narrow-bore reversed-phase C18-HPLC column
Alkalinization
 Assay 49
1ATKKYISYGALQKNSV
PCSRRGASYYNCKPGA
QANPYSRGCSAITRCRS49
5,346.80 115
25kD and 
120kD 
two protein 
components
No No N/D
Arabidopsis non- specific development of multiple 
plant organs
N N/A mutation
 screening
51
1MEMKRVMMSSAERSKEKKRSISRRLG
KYMKEQKGRIYIIRRCMVMLLCSHD51
6209D
pI 10.52
(predicted)
N/D N/D N/D N/D
Arabidopsis shoot apex and young leaves
restrict polarity-dependent
cell proliferation during wt 
leaf morphogenesis
N N/A
mutation
 screening 53
1MAPEENGTCEPCKTFGQKCSHVVKKQRA
KFYILRRCIAMLVCWHDQNHDRKDS53
6.2kD
(predicted) N/D N/D N/D N/D
Arabidopsis shoot apical
 meristems
(SAM)
balance cell proliferation 
and differentiation N
gel chromatography, HR 10/30 column with 
superose 6 resin
 CLV3 in each fraction assayed by dot blots
G-50 Sephadex column
mutation
 screening 12
1RTVPhSGPhDPLHH12 1344.6 96
CLV1/CLV2
complex No
hydroxylation
 of prolines CLE
Arabidopsis
embryonic and 
seedling root, with 
low expression
 in aerial parts.
correct auxin-cytokinin 
homeostasis to modulate  
root growth &
leaf vascular pattering
N N/A N/A 36
1MKPRLCFNFRRRSISPCY
ISISYLLVAKLFKLFKIH36
4.6kD N/D N/D
ethylene/
cytokinn 
& auxin
N/D N/D
Brassica 
expressed 
post-meiotically 
in both the 
microspores
and the tapetum
male determinant of Self 
incompatibility
N N/A Pollination 50 SP11-S8: NLMKRCTRGFRKLGKCTTLEEEKCK
TLYPRGQCTCSDSKMNTHSCDCKSC
<8 kD 74-81
SRK
female 
determinant of 
SI
SLG, 
enhance the 
strength of 
the SI 
reaction
No SCRL
Nicotiana 
alata stigma and style
S-allele-specific pollen 
rejection in the style N N/A N/A 77
1RDMVDPSISLLEPNNDKKTNGMNDATL
QKIGGKVGMFFDFMCAACKCQKGNND
NNDNDNDNDNDNNNNNDIVCQTVCC77
8.6 kD
calculated
pI 3.76 
(predicted)
101 N/D N/D N/D N/D
maize
egg apparatus  (egg 
cell and two 
synergids)
short-range pollen tube 
attraction by the female 
gametophyte
N N/A N/A 94
1MSSCPAIVNMKDDDGIGAMGAAVAFA
AMGVFGIYFLWPVVGPTSAGMMMKAPG
AAGWVICRAVFEANPQLYPTILRTAGA
AAAAATFAACSIAS94
N/D N/D N/D N/D N/D EAL
maize
egg cells and
 microspores
development and 
maturation
 of leaf and 
reproductive tissues
N N/A N/A 27 1MLWGVLFQFMWAVVSLVVTALVACWAK27 N/D N/D N/D N/D N/D N/D
CLAVATA3
(CLV3)
RALF
TLA1
Egg 
Apparatus 1
SCR/SP11
POLARIS
(PLS)
HT
ROTUNDIFOLIA4
 (ROT4)
DEVIL1
(DVL1)
RTFL/DVL
 
Continued 
 
  16
myo-Inositol-1,2,3,4,5,6-hexakisphosphate 
History background 
myo-Inositol-1,2,3,4,5,6-hexakisphosphate (InsP6), also called phytic acid, is myo-
inositol (Ins) with six phosphate groups attached to its six carbons.  Ins is a member of 
the B vitamins, playing a central role in growth and development, and several pathways 
in plant cells including IAA metabolism, cell-wall polysaccharide and cyclic alcohol 
synthesis, and the phosphatidylinositol (PtdIns)/Ins phosphate pathways (Loewus and 
Murthy, 2000).  InsP6 was first brought to attention in 1872 by Pfeffer who reported that 
subcellular particles in wheat endosperm contain a calcium/magnesium salt of organic 
phosphate.  In 1908, Neuberg proposed a structure that contained three cyclic 
pyrophosphate moieties, whereas in 1914, Anderson proposed a structure in which the six 
hydroxyl groups on myo-inositol are esterified with orthophosphate moieties (Cosgrove, 
1980a; Lasztity and Lasztity, 1990; Harland and Morris, 1995).  In 1969, NMR 
spectroscopy eventually resolved the dilemma in favor of the latter (L.F. Johnson, 1969).  
InsP6 is known to be ubiquitous in eukaryotic cells and is the most abundant inositol 
phosphate derivative in late 1980s and 1990s (Sasakawa et al., 1995).   
 
myo-Inositol-1,2,3,4,5,6-hexakisphosphate in plant seed 
InsP6 is the major form of phosphorus in seeds and it also accumulates in other 
plant tissues and organs, including pollen, roots, tubers and turions (Cosgrove, 1980b; 
Raboy, 1997).  It can represent from 1 to several percent of a typical seed’s dry weight, 
about 75 ± 10% of a seed’s total P, and normally more than 90% of a mature seed’s total, 
acid-extractable Ins phosphates (Raboy, 1997).   
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Plants take up phosphorus from soils to develop seeds and seeds use most of the 
phosphorus in InsP6.  A recent global estimate (Lott et al., 2000) of net InsP6 production 
by seed crops represented more than 50% of all phosphorus fertilizer consumed annually, 
suggesting that seed InsP6 represents a major pool in phosphorus flux through the global 
agricultural ecology.  As a result, InsP6 and its degradation products comprise the most 
abundant organic phosphorus form in soils. 
InsP6 usually exists as mixed phytate salts of the mineral cations K+, Mg2+, Ca2+, 
Mn2+ and Zn2+ in mature seeds.  During seed development, it serves as a counter-ion for 
the mineral storage and retrieval processes in a mineral-, tissue- and stage-specific 
fashion.  A recent paper (Otegui et al., 2002) reported that developing Arabidopsis 
thaliana seeds store K+, Mg2+ and Ca2+ as phytates in protein storage vacuoles globoids 
in the embryo, Zn2+ as phytates in the chalazal vacuolar compartment, and Mn2+ as 
phytates in the chalazal endoplasmic reticulum.  The transient storage of Mn2+ and Zn2+ 
as phytates and subsequent redistribution during seed development reflects different 
physiological or metabolic demands for Mn2+ and Zn2+.   
InsP6 accumulates in a linear fashion throughout seed development and degrades 
to lower-phosphate inositol phosphates during germination.  Early studies hypothesized 
these results are due to the maintenance of homeostasis of both Pi and cellular P (Strother, 
1980; Raboy and Dickinson, 1987).  Nonetheless, recent studies of transgenic plants with 
low phytic acid (lpa) mutations revealed that InsP6 metabolism during seed development 
is not essential to P homeostasis, in that numerous pathways depends on Ins or Pi supply 
and/or homeostasis and many plant lpa genotypes exhibited viability as well as relatively 
normal appearance of seed.  This result also suggested that InsP6 accumulation in seeds 
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may attribute mainly to efficient storage and retrieval of P and minerals essential for 
survival and successful germination in natural environment (Raboy et al., 2000; Dorsch et 
al., 2003).   
 
Metabolism in eukaryotic cells 
Since the discovery of Ins(1,4,5)P3 as a second messenger in signal transduction, 
the metabolism of this compound and its derivatives has been widely studied.  Among 
these derivatives, the relatively massive and more polar InsP6 present in many cells has 
been brought to researchers’ attention.  Later on, similar chromatographic methods led to 
the discovery of its more highly phosphorylated pyrophosphate-containing (PP-Ins 
phosphate) derivatives such as the 5-PP-Ins(1,2,3,4,6)P5 and 5,6-bis-PP-Ins(1,2,3,4)P4 
(Figure 4).  The same process also led to the discovery of a non- InsP6 inositol phosphate, 
containing the same 6 moles of phosphate per mole of Ins, such as 5-PP-Ins(1,3,4,6)P4 
(Raboy, 2003).  
Understanding the metabolism of InsP6 and its derivatives facilitates elucidation 
of molecular mechanisms of their biological functions.  Figure 5 shows the modified 
structural metabolic pathways comprised of five parts and centered on InsP6 (Raboy, 
2003).  The early or substrate supply pathway is focused on Ins synthesis and supply in 
which D-glucose 6-phosphate is converted to Ins, Ins(3)P1 and phosphatidylinositol 
(PtdIns).  The inositol phosphate early intermediate pathway located in the top left 
proceeds via soluble inositol phosphates to Ins(3,4,6)P3, and then to Ins(1,4,5)P3.  In the 
top right is the phosphatidylinositol phosphate early intermediate pathway, where 
Ins(1,4,5)P3 is produced via PtdIns phosphate intermediates.  The hub pathway in the 
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center converts Ins trisphosphates to Ins(1,3,4,5,6)P5 or other Ins pentaphosphates 
followed by their conversion to InsP6.  The late inositol polyphosphate pathways are at 
the bottom, where InsP6 or other Ins polyphosphates are utilized to produce PP-Ins 
phosphates.   
 Ins(3)P1 is produced from D-glucose 6-phosphate by myo-inositol (3) P1 synthase 
(MIPS).  In plants, Ins is involved in various metabolic pathways including phospholipid 
or InsP6 synthesis, biogenesis of cell wall polysaccharides and stress-related responses 
(Loewus and Murthy, 2000).    MIPS has been shown to mobilize in a tissue-specific 
manner in response to salinity stress (Nelson et al., 1998).  It is induced by ABA which 
leads to subsequent accumulation of InsP6 by Ins synthesis (Flores and Smart, 2000).  
Additionally, MIPS is induced at sites proximal to InsP6 accumulation in rice seeds 
(Yoshida et al., 1999).   
The first strong evidence for sequential phosphorylation of Ins(3)P1 was from 
investigation in Dictyostelium (Stephens and Irvine, 1990) in which Ins(3)P1 was 
converted to Ins(3,6)P2, Ins(3,4,6)P3, Ins(1,3,4,6)P4  Ins(1,3,4,5,6)P5 and InsP6.  A similar 
pathway to InsP6 was found in duckweed, Spirodela polyrrhiza (Brearley and Hanke, 
1996), consisting of a complete sequence – Ins(3)P1, Ins(3,4)P2, Ins(3,4,6)P3, 
Ins(3,4,5,6)P4, Ins(1,3,4,5,6)P5.    
Ins P6 synthesis via PtdIns phosphate early intermediates is well established.  The 
action of phospholipase C on the lipid PtdIns(4,5)P2 yields Ins(1,4,5)P3 and 
diacylglycerol.  In yeast (York et al., 1999), Drosophila melanogaster (Seeds et al., 2004) 
and Arabidopsis thaliana (Stevenson-Paulik et al., 2002), Ins(1,4,5,6)P4 is produced from 
Ins(1,4,5)P3 via IPK2 (Ins P3 3-/5-/6-Kinase), and then Ins(1,3,4,5,6)P5 from this InsP4 
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isomer also via IPK2, and finally IPK1 produces InsP6.  Nonetheless, in human cells 
(Verbsky et al., 2005), the synthesis of InsP6 works through the isomerization of 
Ins(1,4,5)P3 to Ins(1,3,4)P3, and the sequential phosphorylation of Ins(1,3,4)P3 to 
Ins(1,3,4,6)P4 by the 5/6 kinase, of Ins(1,3,4,6)P4 to Ins(1,3,4,5,6)P5 by a 5-kinase, and of 
InsP5 to InsP6 by a 2-kinase.   
More importantly, InsP6 was reported to inhibit tumor promotion by targeting 
phosphatidylinositol-3 kinase (PtdIns 3-Kinase) (Huang et al., 1997), although there is no 
pathway established linking PtdIns 3-Kinase to InsP6 synthesis.  In mammals and yeast, 
PtdIns 3-kinases are involved in mitogenesis, apoptosis, trafficking of membrane proteins, 
glucose uptake, and activation of intracellular signaling molecules such as rac, ras, rab, 
MAP kinase, protein kinase B/Akt, protein kinase C and JNK/p38 kinase (Munnik et al., 
1998; Leevers et al., 1999; Meijer and Munnik, 2003).  Additionally, the structure of 
InsP6 is similar to D-3-deoxy-3-fluoro-ptdIns, a potent PtdIns 3-kinase inhibitor (Powis et 
al., 1995).  It is likely that InsP6 can inhibit PtdIns 3-kinase in plants to regulate plants 
growth and development. 
Enzymes hydrolyzing Ins P6/phytic acid are termed phytases, a special class of 
phosphatases catalyzing the sequential hydrolysis of phytic acid (Cosgrove, 1980a).  Two 
classes of acid phytases, 6-phytase (EC 3.1.3.26) and 3-phytase (EC 3.1.3.8), hydrolyze 
InsP6 to Ins(2)P1 (Cosgrove, 1980a).  An usual alkaline phytase present in lily pollen and 
seeds starts dephosphorylation on the 5 position of InsP6 (Barrietos et al., 1994).   
Multiple phytases with different specificity and biochemical properties are involved in 
the hydrolysis of InsP6.  The hydrolysis of InsP6 to lower-phosphate inositol phosphates 
via phytases might be involved in seed germination and dormancy in plants.  
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Figure 4.  Structures of myo-inositol (Ins) and various inositol phosphates including Ins 
(1,2,3,4,5,6) P  or phytic acid modified from (Raboy, 2003) 6
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Figure 5.  Structural metabolic pathways from glucose 6-P to Ins(3)P , and from Ins(3)P1 1 
to InsP6, and beyond, in eukaryotic cells, modified from (Raboy, 2003).  The early or 
substrate supply pathway is focused on Ins synthesis and supply in which D-glucose 6-
phosphate is converted to Ins, Ins(3)P1 and phosphatidylinositol (PtdIns).  The inositol 
phosphate early intermediate pathway located in the top left proceeds via soluble inositol 
phosphates to Ins(3,4,6)P3, and then to Ins(1,4,5)P 3.  In the top right is the 
phosphatidylinositol phosphate early intermediate pathway, where Ins(1,4,5)P3 is 
produced via PtdIns phosphate intermediates.  The hub pathway in the center converts Ins 
trisphosphates to Ins(1,3,4,5,6)P5 or other Ins pentaphosphates followed by their 
conversion to InsP6.  The late inositol polyphosphate pathways are at the bottom, where 
InsP6 or other Ins polyphosphates are utilized to produce PP-Ins phosphates.   
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Cellular functions and signaling transduction 
In addition to storage and retrieval of phosphorus, mineral and Ins in plant seeds, 
InsP6 has a wide-ranging array of important physiological activities (Shears, 2001).  
Larsson et al. reported that InsP6 inhibited serine-threonine protein phosphatases and 
activated L-type Ca2+ channels (Larsson et al., 1997).  The plant drought-stress hormone, 
abscisic acid (ABA), elevates InsP6 levels in Solanum tuberosum stomatal guard cells.  
InsP6 in turn inactivates the plasma membrane K+-inward conductance which is a well 
characterized target of ABA response, in a cytosolic calcium-dependent manner (Lemtiri-
Chlieh et al., 2000).  InsP6 also functions as an endomembrane-acting calcium release 
signal (Lemtiri-Chlieh et al., 2003).  These findings suggest that InsP6 is a downstream 
component of the ABA signaling pathway.   
InsP6 stimulates insulin exocytosis by the activation of protein kinase C (Efanov 
et al., 1997).  The 1, 2, 3 (axial-equatorial-axial) phosphate grouping in InsP6 provides a 
specific interaction with iron during iron transport through the cytosol or cellular 
organelles, so that InsP6 inhibits the catalysis of hydroxyl radical formation by iron and 
acts as a cellular antioxidant (Graf et al., 1987; Hawkins et al., 1993).  Additionally, InsP6 
was purified from HeLa cell-free extracts.  It is bound by DNA-protein kinase and 
stimulates DNA-protein kinase-dependent end-joining in vitro (Hanakahi et al., 2000).  
InsP6 also has specific inhibitory effects on the agonist-induced loss of responsiveness of 
the rat substance P receptor (Sasakawa et al., 1994).  Other functions of InsP6 include 
regulation of mRNA export (York et al., 1999), priming of stimulus-dependent 
respiratory burst in neutrophils (Eggleton et al., 1991), preventing kidney stone formation 
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(Grases et al., 1998), mediation of neurotransmission (Vallejo et al., 1987), inhibition of 
cancer cells (Vucenik and Shamsuddin, 1994), etc.   
Nevertheless, InsP6 was historically considered as an antinutrient in that it can 
decrease the bioavailability of essential dietary minerals in human beings due to its 
ability to bind them.  In the late 1980s, InsP6 was shown to possess striking anticancer 
action.  InsP6 inhibited the growth of all tested cell lines in a dose- and time-dependent 
manner (Shamsuddin and Vucenik, 2005).  Reduction of the elevated rate of cell 
proliferation to the normal level has been observed both in intact animals (Wattenberg 
and Chalcones, 1995; Challa et al., 1997; Gupta et al., 2003) and in cultures of human 
malignant cells (Shamsuddin et al., 1992; Sakamoto et al., 1993; Shamsuddin and Yang, 
1995; Ferry et al., 2002; Singh et al., 2003).  Moreover, cells from different origins have 
different sensitivities to InsP6, indicating that the mechanism of InsP6 anticancer action 
varies in cell types.  Can inhibition of somatic embryo growth by InsP6 in plants share the 
same mechanism as some cancer cells in animals?  A proposed mechanism regarding 
inhibition to early-stage somatic embryos is described in the discussion section.    
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CHAPTER II 
 
EXPERIMENTAL PROCEDURES 
 
Materials and Equipment 
Materials 
LP cones were collected weekly throughout the sequence of embryo development 
from multiple open-pollinated mother trees over the last ten years.  Seeds from Union 
Camp tree UC5-1036, located in a seed orchard near Bellville, GA, were collected in 
years 1996 to 1998.  Seeds from tree S4PT6, located in a Boise Cascade breeding orchard 
near Lake Charles, Louisiana, were collected in year 1997, 1998 and from Texas in years 
2002, 2003 and 2005.  Cones were shipped to IPST in a cooler with blue ice, received 
within 24-48 hours after the collection period and stored at 4 oC.  
Tris base, deuterium oxide (min. 99.96 atom% D), tributylphosphine (TBP), 
iodoacetamide, trypsin, bromophenol Blue, Dowex resin 50WX8-200, and phytic acid 
dodecasodium salt hydrate from rice were obtained from Sigma-Aldrich (St Louis, MO).  
50% (w/w) phytic acid water solution was obtained from Chromadex (Irvine, CA).  
HPLC grade acetonitrile and methanol, sodium chloride, sodium phosphate monobasic 
and dibasic, ammonium acetate, trifluoroacetic acid (TFA), formic acid, ammonium 
sulfate, triethylammonium acetate (TEAA), sodium dodecyl sulfate (SDS), glycerol, and 
β-mercaptoethanol were purchased from Fisher Scientific (Pittsburgh, PA).   
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Abscisic acid, ammonium nitrate, 6-benzylaminopurine (BAP), biotin, boric acid,  
calcium nitrate tetrahydrate, cobalt chloride hexahydrate, copper sulfate pentahydrate, 
folic acid, Gelrite, glutamine, glycine, iron sulfate heptahydrate, kinetin, magnesium 
chloride hexahydrate, magnesium nitrate hexahydrate, magnesium sulfate heptahydrate, 
manganese sulfate heptahydrate, N-morpholinoethanesulfonic acid (MES), myo-inositol, 
nicotinic acid, potassium iodide, potassium hydroxide, thiamine hydrochloride and zinc 
sulfate heptahydrate were obtained from Sigma Aldrich (St Louis, MO).  Casamino acids 
were purchased from Beckton Dickinson (Franklin Lanes, NJ).  2,4-
Dichlorophenoxyacetic acid was purchased from Chem Service (West Chester, PA).  
Potassium dihydrogenphosphate, potassium hydrogenphosphate, potassium nitrate, 
sodium ethylenediaminetetraacetic acid and sucrose were obtained from JT Baker 
(Phillipsberg, NJ).  Acrodisc Syringe filter (0.2 μm HT Tuffryn Membrane Low Protein 
Binding Non-Pyrogenic) was purchased from Pall Life Sciences (East Hills, NY). 
 
Equipment 
All FPLC purification was performed at 4 oC by column chromatography on an 
ÄKTA™ Explorer (GE Healthcare, formerly Amersham Bioscicences, Piscataway, NJ) 
with a fraction collector 950 installed. The separation unit was controlled by the 
UNICORN software (GE Healthcare, Piscataway, NJ).  All centrifugation was performed 
in a table top Eppendorf microcentrifuge 5415C (Brinkmann Instruments, Inc., Westbury, 
NY).  Ultrafiltration was accomplished using stirred cells (Amicon, Beverly, MA) with 
Millipore YM1 or YM3 membranes (Millipore, Bedford, MA).  
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All reversed-phase HPLC purification and characterization were performed at 
room temperature either on a WatersTM LC Module I plus HPLC system (Waters, Milford, 
MA) or on a Beckman Coulter HPLC system (Beckman Coulter, Fullerton, CA).  The 
former was controlled by Millennium Chromatography Manager Software.  The latter 
consisted of a System Gold 126 Solvent Module, a System Gold 508 Autosampler and 
was controlled by 32 Karat software.  All capillary electrophoresis were carried out on a 
Proteolab PA 800 (Beckman Coulter, Fullerton, CA), also under the control of 32 Karat 
software.  All SDS-PAGE and Native-PAGE were performed on a Pharmacia 
PhastSystem (GE Healthcare, formerly Amersham Bioscicences, Piscataway, NJ) 
All lyophilization was carried out on a Labconco Centrivap system (Labconco, 
Kansas City, MO), which consisted of a cold trap, a concentrator and a Welch DirecTorr 
8915 vacuum pump (Welch Vacuum, Skokie, IL).  All osmolalities were measured on a 
Wescor 5500 vapor pressure osmometer (Wescor, Logan, Utah)  
The LC/MS and LC/MS/MS characterization were accomplished on an Applied 
Biosystems/MDS SCIEX 4000 QTRAPTM (Linear Ion Trap Quadrupole) LC/MS/MS 
system (Applied Biosystems, Foster City, CA), which was interfaced with two Shimadzu 
LC-10ADVP HPLC pumps (Shimadzu, Columbia, MD) and a PE200 autosampler 
(Perkin Elmer, Waltham, MA).  The capillary flow was obtained by an LC Packings 
Acurate precolumn flow splitter (Dionex, Sunnyvale, CA).  The exact mass measurement 
was carried out on an Applied Biosystems/MDS SCIEX QSTAR® XL Hybrid (hybrid 
quadrupole time-of-flight mass spectrometer) LC/MS system (Applied Biosystems, 
Foster City, CA), which was interfaced with an UltiMate nano and capillary LC system 
by LC Packings (Dionex, Sunnyvale, CA) and a TriVersaTM NanoMate (Advion, Ithaca, 
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NY).  The MALDI characterization was performed on an Applied Biosystems 4700 
Proteomics Analyzer with TOF/TOFTM Optics (Applied Biosystems, Foster City, CA).  
All NMR spectra were recorded on a Bruker DRX 500 spectrometer (Bruker 
Biospin, Billerica, MA).   
 
Female Gametophyte Collection and Water Extraction 
Collection 
Cones were pried open and seeds were isolated.  Seeds were then cracked open 
with a hemostat.  The FG tissue was split with fine-tipped forceps, and integuments and 
nucellar tissue were removed from the ovule.  The dominant zygotic embryo was 
removed from the FG and individual embryos were observed through a dissecting 
microscope, evaluated for stage of development (Pullman and Webb, 1994), sorted by 
stage and tissue type, and placed in vials partially immersed in liquid nitrogen.  Stage 9 
embryos were categorized by the week they were collected: 9.1 (stage 9, week 1), 9.2 
(stage 9, week 2), etc.  Twenty same-staged embryos or FGs were collected per vial, 
frozen and stored in a -70oC freezer.  Collections for each tree and tissue type ranged 
from stage 1 (collected 1 to 2 weeks after estimated fertilization) to stage 9.12 (shortly 
before cone harvest). 
 
Water extraction 
The stored FG tissue (from 40 FGs) was powdered by crushing with a mortar and 
pestle under liquid nitrogen, and extracted with 10 ml of deionized water and stirred at 4 
oC for an hour.  The resulting mixture was aliquoted into mirocentrifuge tubes; the 
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supernatant was combined and collected after centrifugation (Baxter Scientific, Biofuge 
13 at 13000 rpm) for 10 min; the pellet was washed with deionized water, vortexed for 1 
min, and centrifuged as above.  The wash was combined with the previous supernatant; 
the resulting solution was filtered with a 0.2 µm syringe filter (Pall life sciences), and 
lyophilized overnight to dryness. 
 
Identification 
Preparation of maintenance and multiplication media (1133 and 1250) 
Media components and concentrations (1133 and 1250) are listed in Table 2.  
Both the media were prepared by mixing all the reagents with the exception of abscisic 
acid (ABA) and glutamine, adjusting the pH to 5.7 with 1N KOH and autoclaving the 
resulting mixture in the absence (1133) or the presence (1250) of Gelrite using the liquid 
cycle (highest temperature of 121 oC).  ABA and glutamine were filter-sterilized through 
a 0.2 µm syringe filter (Pall, East Hills, NY) and added to the autoclaved media mixture.  
Two ml of the subsequent media mixture was poured into each well of a 24-well Costar 
#3526 cluster plate (Corning, Corning, NY).  
 
Embryogenic Cell Culture Maintenance 
Embryogenic cultures were maintained as described in (Pullman et al., 2003c).  
Cultures were stored in 250-ml Erlenmeyer flasks incubated in the dark at 20 to 22 oC.  
Every seven days, the contents of the culture flask were poured into sterile centrifuge 
tubes and settled for 20 min.  The old liquid media was decanted, settled cell volumes 
were measured to monitor the cell growth, and cells were resuspended in media 1133 at a 
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density of 1 ml settled cells/9 ml medium (5 ml of settled cells/45 ml of media 1133).  
The cultures were rotated at 90-100 rpm and maintained with weekly transfers at the 
same ratio of cells to medium.   
 
Early-stage Somatic Embryogenic Multiplication Bioassay 
Single stage 2 or 3 somatic embryos were isolated by forceps from suspension 
culture and placed on 2 ml of multiplication medium 1250 contained in 24-well Costar 
#3526 cluster plates.  Genotypes of early-stage somatic embryos used in bioassays were 
500, 112, 387, 51 and 279.  Each treatment was composed of 40 single early-stage 
somatic embryos in four replicates of 10 embryos each.  The female gametophyte (FG) 
extract lyophilized fractions were each dissolved in 2 ml of deionized water, adjusted to 
pH 5.7 with 0.1 M NaOH or 0.1 M HCl.  Each fraction was filter sterilized by a 0.2 µm 
syringe filter (Pall, East Hills, NY) and topically applied on early-stage somatic embryos 
at 50 µl/well, which corresponded to a concentration of approximately ½ FG per embryo. 
The embryos grew in the dark at 23-25 oC; after four to seven weeks, the diameter of the 
embryogenic tissue was measured with a dissecting microscope using a calibrated 
eyepiece reticle.  
 
Statistic Analysis 
All the data were evaluated by multifactor analysis of variance.  The significant 
differences between means of each treatment were determined by the Multiple Range 
Test at 95% level of significance.  Both analyses were performed using Statgraphics Plus 
Version 4.0 (Manugistics, Rockville, MD). 
  31
Table 2.  Media ingredients of media 1133 and 1250 (Pullman et al., 2006). 
Components  Media and components (mg/l)  
  1133 1250 
NH4NO3  603.8 603.8 
KNO3  909.9 909.9 
KH2PO4  136.1 136.1 
Ca(NO3)2●4H2O  236.2 236.2 
MgSO4●7H2O 246.5 246.5 
 Mg(NO3)2●6H2O  256.5 256.5 
MgCl2●6H2O 101.7 101.7 
 KI  4.15 4.15 
H3BO3  15.5 15.5 
MnSO4●H2O 10.5 10.5 
 ZnSO4●7H2O 14.4 14.4 
Na2MoO4●2H2O 0.125 0.125 
 CuSO4●5H2O 0.125 0.125 
  CoCl2●6H2O 0.125 0.125 
FeSO4●7H2O   6.95 9.95 
Na2EDTA 9.33 9.33 
Sucrose  30,000 30,000 
Myo-inositol  1,000 1,000 
Casamino acids  500 500 
L-Glutamineb  450 450 
Thiamine _HCl  1 1 
Pyridoxine HCl  0.5 0.5 
Nicotinic acid  0.5 0.5 
Glycine  2 2 
MES  – 250 
Biotin  – 0.05 
Folic acid  – 0.5 
2,4-D  1.1 1.1 
BAP  0.45 0.45 
Kinetin  0.43 0.43 
Abscisic acid 1.3 1.3 
Gelrite  – 2500 
pH  5.7 5.7 
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Liquid Chromatography Isolation 
Gel filtration chromatography I 
A Superdex 75 10/300 GL gel filtration column (10×300 mm, GE Healthcare, 
Piscataway, NJ) was used as the first isolation column.  Lyophilized powder 
corresponding to the water extract of 30 FGs was dissolved in 250 µl of 150 mM NaCl.  
After centrifugation at 14000 rpm for 10 minutes, the supernatant was separated by the 
Superdex 75 column at a flow rate of 0.5 ml/min using 150 mM NaCl as an eluent.  The 
column was pre-equilibrated with the same eluent for 118 min at 0.5 ml/min.  The elution 
was monitored at wavelengths of both 254nm and 280 nm at 4 oC.  The isocratic elution 
lasted for 118 min.  Fractions were grouped and numbered according to the elution of 
each peak.  Each collected fraction was ultrafiltered against a Millipore YM 1 membrane 
(1000 Da cutoff), which was contained in an Amicon ultrafiltration cell (Amicon 8200).  
Deionized water was added three times and the duration of ultrafiltration was 
approximately six hours.  The retentate was collected, divided into aliquots and 
lyophilized overnight to dryness.  Each fraction was assayed as described above. 
 
Reversed Phase Chromatography 
The reversed phase columns attempted for the second-step liquid chromatography 
were a Phenomenex Jupiter C5 column (5 µm, 300 Å, 4.6×250 mm, Phenomenex, 
Torrance, CA), an Alltech ProSphere C18 column (5 µm, 300 Å, 4.6×150 mm, Alltech, 
Deerfield, IL) and a Vydac 218TP C18 column (3 µm, 300 Å, 1.0×250 mm, Vydac, 
Deerfield, IL).   
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The Phenomenex Jupiter C5 column attached to a wide-pore C5 guard cartridge 
(3.0×4 mm, Phenomenex, Torrance, CA) was connected to a Beckman Coulter HPLC 
system.  Water containing 0.1% TFA was used as mobile phase A; mobile phase B 
consisted of acetonitrile in 0.085% TFA.  The flow rate was 1 ml/min and a wavelength 
of 215 nm was used for the detector.  The linear gradient started at 15% B for 3 min, 
increased to 35% B over 30 min, and returned to 15% B in 3 min.  
 
Hydrophobic Interaction Chromatography (HIC) 
The hydrophobic interaction columns attempted for the second-step liquid 
chromatography were a HiPrep Butyl FF column (16× 100 mm, GE Healthcare, 
Piscataway, NJ), a HiPrep Phenyl FF column (high sub, 16×100 mm, GE Healthcare, 
Piscataway, NJ) and a HiPrep Octyl FF column (16× 100 mm, GE Healthcare, 
Piscataway, NJ).  For the HiPrep Butyl FF column, various concentrations of sodium 
phosphate and sodium acetate were used as the buffer depending on the desired pH in the 
range from 2.5 to 7.0.  Various amounts of ammonium sulfate were added to eluent A in 
order to adjust the retention of compounds on the HiPrep Butyl FF column, and various 
gradients were carried out to adjust the resolution of separation.  For the other two HIC 
columns, similar attempts were made for the same purpose.  The final conditions of the 
HiPrep Butyl FF column used for collecting fractions that were bioassayed were: eluent 
A consisted of 50 mM sodium phosphate buffer containing 1.5 M ammonium sulfate and 
eluent B consisted of 50 mM sodium phosphate buffer, both at pH 2.5.  The flow rate was 
maintained at 5 ml/min, and the elution profile was monitored at 215 nm.  A 48-min 
elution with linear gradient segments was applied: 0% B for 10 min, 0% to 50% B over 
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20 min, 50% to 100% B for 8 min, and 100% B for 10 min.  All fractions were pooled, 
collected, ultrafiltered against a Millipore YM3 membrane (3000 Da cutoff), lyophilized 
to dryness, and assayed. 
 
Ion Exchange Chromatography 
Strong cation exchange chromatography   
A Mono S strong cation exchange column (5× 50 mm, GE Healthcare, 
Piscataway, NJ) was used as the second isolation column.  Bioactive fraction F2 
corresponding to 40 FGs was re-dissolved in 300 µl of eluent A, 20 mM sodium 
phosphate buffer at pH 2.5, and further separated by the Mono S column at 1.5 ml/min 
and 4 oC.  The elution was monitored at a wavelength of 215 nm in a 56-min gradient.  
Eluent B was eluent A containing 2 M NaCl.  The gradient started at 0% B for 9 min, 0% 
to 50% B over 27 min, 50% to 100% B for 2 min, and 100% B for 18 min.  All fractions 
from the Mono S column were pooled and grouped, ultrafiltered against a Millipore YM1 
(1000 Da cutoff) membrane, and lyophilized to dryness.  
 
Strong anion exchange chromatography   
The third-step LC was achieved on a Mini Q strong anion exchange column (4.6
×50 mm, GE Healthcare, Piscataway, NJ).  After each fraction was assayed for early-
stage embryo multiplication, amount corresponding to 40 FGs of the bioactive fraction 
F2-S1 eluting from 0.5 to 2.5 min was re-dissolved in 300 µl of eluent A, 20 mM Tris-Cl 
buffer at pH 8.0, and loaded on the Mini Q column which was pre-equilibrated with 10 
ml of the eluent A at 0.5 ml/min.  Eluent B was eluent A containing 2 M NaCl.  The flow 
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rate of elution was 0.5 ml/min, and the elution profile was monitored at 215 nm.  An 89-
min gradient was applied: 0% B for 23 min, 0% to 30% B over 58 min, 30% to 100% B 
for 4 min, and 100% B for 4 min.  Fractions were pooled, ultrafilted against a Millipore 
YM3 (3000 Da cutoff) membrane, and lyophilized.  Each fraction was submitted to 
embryo multiplication assay.  An optimized desalting procedure was carried out by 
treating the bioactive fraction F2-S1-Q6 eluting from 52 to 69 min from Mini Q pooled 
and lyophilized directly after elution, without ultrafiltration.  
 
Weak anion exchange chromatography   
A HiPrep DEAE (16×100 mm, GE Healthcare, Piscataway, NJ) column was 
used in an attempt to fractionate F2 for the second liquid chromatography separation after 
the Superdex 75 column.  Both 20 mM bis-Tris and Tris were used as the buffer at 
various pH values ranging from 6.5 to 7.7 to adjust the resolution of separation and the 
retention of compounds on the column, and various gradients were applied for the same 
purpose.   
 
Gel filtration chromatography II 
The last-step purification was accomplished on a Superdex Peptide 10/300 GL gel 
filtration column (10×300 mm, GE Healthcare, Piscataway, NJ).  The lyophilized 
bioactive fraction F2-S1-Q6 (corresponding to 10 FGs) was re-dissolved in 150 µl of 100 
mM ammonium acetate buffer at pH 5.5, the eluent of the Superdex Peptide column.  F2-
S1-Q6 was desalted and further fractionated at a flow rate of 0.2 ml/min for 158 min.  
The detecting wavelengths were set at 215 nm and 280 nm.  The column was equilibrated 
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with the same buffer at 0.5 ml/min for 138 min before sample loading.  Fractions were 
pooled, collected and lyophilized to dryness.  Aliquots of each fraction was applied onto 
bioassay and analyzed by LC/MS.   
 
 
Mass Spectrometry Characterization 
LC/MS 
LC/MS under positive polarity 
  The mass spectrometer was an Applied Biosystems 4000 QTRAP (Linear Ion 
Trap Quadrupole) LC/MS/MS system.  The ESI interface was operated in positive mode 
at 5500 V.  A Vydac C8 capillary column (5µ, 300 Å, 0.3×250 mm, Deerfield, IL) was 
coupled to a Shimadzu LC-10ADVP.  Full scan mass spectra were recorded from m/z 500 
to 2000 amu at 1000 amu/s by the linear ion trap as an enhanced mass spectrometric 
(EMS) scan, with declustering potential at 90 V.  The total flow rate was 0.6 ml/min, 
which was split to 5 µl/min to the column.  Mobile phase A consisted of 2% acetonitrile, 
98% water and mobile phase B was 80% acetonitrile, 20% water both containing 0.1% 
formic acid as the ion pair reagent.  The elution protocol was comprised of a 1 min 
column pre-equilibration with 100% A, followed by 10.0 µl sample injection, a 5 min 
sample load  and wash with 100% A.  The gradient was 105 min in total: 0% B for 12 
min, 0 to 40% B over 63 min, 40 to 100% B for 5 min, 100% B for 8 min, back to 0% B 
for 5 min, re-equilibration for 12 min.   
 
LC/MS under negative polartiy 
  37
LC/MS under negative ion polarity was achieved on the same Applied 
Biosystems 4000 QTRAP LC/MS/MS system by two different LC approaches.  The first 
approach used a C5 Jupitor reversed phase column (4.6× 250 mm, Phenomenex, 
Torrance, CA) with mobile Phase A consisting of 95% water, 5% acetonitrile and mobile 
phase B comprised of 70% acetonitrile, 30% water both containing 10 mM ammonium 
acetate at pH 5.5.    An 80-min gradient was applied at a flow rate of 1 ml/min: 0% B for 
5 min, 0 to 50% B over 40 min, 50 to 100% B for 15 min, 100% B for 5 min, back to 0% 
B for 5 min, re-equilibration for 10 min.  The second approach used a Vydac C8 capillary 
column (0.3×250 mm, Deerfield, IL).  Mobile phase A was comprised of 2% acetonitrile, 
98% water and mobile phase B was 80% acetonitrile, 20% water both containing 10 mM 
triethylammonium acetate buffer at pH 7.0.  The flow rate was maintained at 5 µl/min.  
The gradient was 105 min in total: 0% B for 12 min, 0 to 55% B over 63 min, 55 to 100% 
B for 5 min, 100% B for 8 min, back to 0% B for 5 min, re-equilibration for 12 min. 
For both methods, the ESI interface was operated under negative ion polarity.  
The turbo ion spray needle was held at negative 4500 V.  Full scan mass spectra were 
recorded from m/z 500 to 2500 amu at a scan rate of 400 amu/s under quadrupole mode, 
with declustering potential at -200 V. 
 
Exact Mass Analysis 
Exact mass analysis under positive polarity
The exact mass analysis under positive polarity of the active fraction from the 
Mini Q column desalted against YM3 membrane (F2-S1-Q6) was carried out on an 
Applied Biosystems QSTAR XL system (Applied Biosystems, Foster City, CA).  The 
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turbo ion spray needle was held at 5500 V.  TOF-MS spectrum was recorded over a mass 
range of m/z 300-2000.  20 FG of F2-S1-Q6 was dissolved in 100 µl of a 
water/acetonitrile (50:50, v/v) mixture and infused to QSTAR XL through an injection 
loop.  The declustering potential was set at 40 V and the focusing potential at 100 V. 
 
Exact mass analysis under negative polarity
Exact mass analysis under negative polarity was obtained from the final active 
fraction from the Superdex Peptide column (F2-S1-Q6-D1B).  The stock solution of F2-
S1-Q6-D1B was prepared by dissolving 25 FG of F2-S1-Q6-D1B in 50 µl of a 
water/methanol (50:50, v/v) mixture containing 0.1% formic acid.  The resulting stock 
solution (5 µl) was diluted in 1 ml of methanol.  Because it was too concentrated for the 
detector limit, a further dilution was performed by mixing 100 µl of the last dilute 
solution with another 1 ml of methanol.  The phytic acid standard used was a 50% water 
solution (w/w, Chromadex, Irvine, CA), 0.2 µl of which was dissolved in 200 µl of a 
water/methanol (50:50, v/v) mixture containing 0.1% formic acid, and 5 µl of the 
resulting mixture was then diluted with 1 ml of methanol.   
The exact mass measurement under negative ion polarity was conducted on the 
QSTAR XL system, with F2-S1-Q6-D1B and phytic acid standard directly infused with 
an automated chip-based nanoelectrospray TriVersaTM NanoMate system (Advion, Ithaca, 
NY).  The NanoMate was controlled by the ChipSoft software (version 7.1.1) and 
comprised of a liquid handling robot equipped with a 96-well plate and a rack of 96 
disposable conductive pipette tips, as well as a microchip containing a 10×10 array of 
nanoelectrospray nozzles (ESI chip, Advion, Ithaca, NY).  The system can automatically 
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infuse 96 samples.  The ESI chip used was chip D (4.1 µm i.d.) containing 100 nozzles.  
For each analysis, a new tip and a nozzle were used.  A low delivery pressure of 0.15 psi 
of nitrogen gas and a negative voltage of 1.6 kV were applied to generate a 
nanoelectrospray plume from a given nozzle when infusing the sample of interest.  TOF-
MS spectra were recorded over the mass range of m/z 300-2000.  The declustering 
potential was held at -150 V and the focusing potential at -200 V.  Data acquisition and 
QSTAR instrument control were performed by Analyst QS software (version 1.1). 
 
MS/MS 
LC/MS/MS under positive polarity
LC/MS/MS spectra of the precursor ion at m/z 661 under positive polarity were 
acquired subsequent to the LC/MS on the QTRAP.  Enhanced product ion (EPI) scans 
were performed subsequent to the enhanced mass spectrometric (EMS) scan at a scanning 
rate of 1000 amu/s over the mass range m/z 50-700 with collision energies at both 40 eV 
and 80 eV.  Data acquisition, and instrument control were performed by Analyst software 
(version 1.4.2). 
 
MS/MS under negative polarity 
Tandem mass spectra of the precursor ion at m/z 659 under negative polarity were 
acquired subsequent to the exact mass measurement on the QSTAR XL interfaced with 
the NanoMate system. The spectra were recorded from m/z 50-700 with collision 
energies at both 40 eV and 80 eV.   
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NMR Characterization 
Standard preparation 
Phytic acid dodecasodium salt hydrate (Sigma, St Louis, MO) from rice was 
converted to InsP6 through cation exchange resin Dowex 50WX8-200 (Sigma, St Louis, 
MO).  The resin (4g) was mixed with 12 ml of 1M NaOH in a beaker, poured onto a filter 
paper and washed with deionized water until the pH of the eluate decreased to 5-6 (tested 
by pH paper).  The resulting resin was transferred to another beaker containing 12 ml of 
1M HCl, mixed thoroughly, poured onto a filter paper and washed until eluate is at 
neutral pH.  A column was packed with the resulting resin in a 10-ml syringe barrel 
which had a small amount of glass wool at the bottom.  Phytic acid dodecasodium salt 
(300.2 mg) was dissolved in approximately 20 ml of water.  The resulting solution was 
loaded onto the column and rinsed with deionized water.  The eluate, which contained the 
InsP6, was collected, divided into 10 aliquots and lyophilized to dryness.  The lyophilized 
product was dissolved in 500 µl of deuterium oxide (min. 99.96 atom% D) and the pH 
adjusted to 8.22 by adding aliquots of concentrated NaOD.  Additional 1H and 31P spectra 
were recorded at different pH values over the range 8.0 – 8.5.   
 
1-Dimensional NMR 
NMR spectra of the final purified active fraction (F2-S1-Q6-D1B) were recorded 
in D2O at 500.13 MHz for 1H with 32 scans, 202.46 MHz for 31P with 64 scans and 
125.77 MHz for 13C with 16386 scans using a multinuclei probe maintained at 280 K on 
a Bruker DRX 500 spectrometer.  F2-S1-Q6-D1B was dissolved in 500 µl of D2O (min. 
99.96 atom% D) and lyophlized to dryness, repeated for three times.  The final 
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lyophilized product was dissolved in 200 µl of D2O (min. 99.96 atom% D) and 
transferred to a symmetrical 5 mm NMR tube (Shigemi, Allison Park, PA) matched with 
D2O containing a pair of insert (4.1×190 mm) and outer tube (4.52 mm ID, 4.965 mm 
OD×180 mm).  The 5mm-OD NMR tube (Wilmad, Buena, NJ) designed for 500 MHz 
NMR instrument was used for all standard recording which share the same conditions as 
those of F2-S1-Q6-D1B, except fewer scans.  1H, 31P, and 13C chemical shifts were 
reported in ppm and assignments for both F2-S1-Q6-D1B and the standard are labeled 
above their respective peaks in the proton spectra with reference to the 4.67 ppm water 
peak.  Coupling constants were determined using the MestRe-C software package and 
spectra were analyzed by MestReNova software.  
F2-S1-Q6-D1B: 1H NMR analysis δ 4.59 (d, 1, H2), 4.09 (q, 2, H4/6), 3.82 (m, 1, 
H5), 3.76 (t, 2, H1/3).  31P NMR analysis δ 2.54 (s, 1, P5), 2.29 (s, 2, P1/3), 2.06 (s, 1, P2), 
1.63 (s, 2, P4/6).  13C NMR analysis δ 77.40 (s, 1, C5), 75.89 (s, 2, C4/6), 74.51 (s, 1, C2), 
73.39 (s, 2, C1/3). 
Commercial InsP6:  1H NMR analysis δ 4.56 (d, 1, H2),  4.08 (q, 2, H4/6),  3.79 (m, 
1, H5),  3.74 (t, 2, H1/3).  31P NMR analysis δ 2.72 (s, 1, P5), 2.54 (s, 2, P1/3), 2.30 (s, 1, P2), 
1.75 (s, 2, P4/6).  13C NMR analysis δ 77.47 (s, 1, C5), 75.77 (s, 2, C4/6), 74.72 (s, 1, C2), 
73.38 (s, 2, C1/3). 
 
1H-1H COSY 
The correlation spectroscopy (COSY) experiment was carried out using the 
standard Bruker program cosygpqf during the 1.5-s relaxation delay on the HOD signal, 
1024 data points in the F2 dimension, and 128 increments in F1.  The data matrix was 
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processed to give a matrix of 1024 ×1024 points, and a sine bell apodization function 
was applied before Fourier transformation.   
 
1H-31P HSQC 
The two-dimensional heteronuclear single quantum correlation (1H - 31P HSQC) 
experiment was carried out using the standard Bruker program hsqcetgpsi2 modified for 
31P gradient strength.  The parameters were 1.5-s recycle delay, 1024 data points in F2, 
128 increments in F1, GARP (globally optimized alternating phase rectangular pulse) 31P 
decoupling during acquisition, and shifted sine-squared apodization before Fourier 
transformation. 
 
1H-13C HSQC 
The two-dimensional heteronuclear single quantum correlation (1H – 13C HSQC) 
experiment was carried out using the standard Bruker program hsqcetgpsi2.  The 
parameters were 1.5-s recycle delay, 1024 data points in F2, 128 increments in F1, GARP 
13C decoupling during acquisition, and shifted sine-squared apodization before Fourier 
transformation. 
 
Gel Electrophoresis -- SDS-PAGE 
All SDS-PAGE and Native-PAGE were performed on a Pharmacia PhastSystem.  
PhastGel high density (GE Healthcare, Piscataway, NJ), a homogeneous polyacrylamide 
gel designed for the separation of peptides and low molecular weight proteins, was used 
for SDS-PAGE.  The gel was run with PhastGel SDS buffer strips made of 3% Agarose 
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IEF, containing 0.20 M Tris, 0.55% SDS at pH 8.1.  The sample buffer stock solution 
was prepared by mixing 1.2 ml of 0.5M Tris-HCl at pH 6.8, 1.0 ml of glycerol, 4.8 ml of 
deionized water, 2.0 ml of 10% (w/v) SDS stock solution and 0.5 ml of 0.1% (w/v) 
Bromophenol Blue stock solution.  285 µl of the buffer stock solution was mixed with 15 
µl of β-mercaptoethanol at a ratio of 19:1 to make the final fresh buffer on the day of the 
experiment.  The low-MW ladder standard (Biorad, Hercules, CA) was diluted at 1:20 in 
the final buffer.   Samples of interest were diluted in various ratios with the final buffer to 
make the consequent volume 20 µl each.  All sample solutions and the ladder solution 
were heated in a water bath at 100oC for 5 min, followed by cooling to room temperature.  
Samples and the ladder were loaded by an 8-well sample applicator and separated at 500 
V, 5.0 mA, 3.0 W, 15 oC for 190 Vh.  Samples were fixed by 2.5% glutaraldehyde in 
deionized water for 4 min, stained by 0.1% PhastGel Blue R solution in 30% methanol 
and 10% acetic acid in deionized water for 60 min, destained by 30% methanol and 10% 
acetic acid in deionized water for four rinses with 44 min in total and preserved by 10% 
glycerol and 10% acetic acid in deionized water for 5 min.  All these staining and 
destaining procedures were performed at 50 oC.   
 
Capillary eletrophoresis -- SDS-gel MW analysis 
The SDS-gel MW analyses were performed on a Proteolab PA 800 (Beckman 
Coulter, Fullerton, CA) under the control of 32 Karat software.  The capillary (50 µm ID, 
57 cm length, bare-fused silica, Beckman Coulter, Fullerton, CA) was first activated by 
0.1 M NaOH basic wash for 5 minutes at 50 psi, followed by 0.1 M HCl acidic wash for 
2 minutes at 50 psi, water rinse for 2 minutes at 50 psi, then filled with SDS-MW gel 
buffer for 10 minutes at 40 psi (Beckman Coulter, CA) and equilibrated with the SDS gel 
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at 15 kV for 10 minutes.  For analyses of samples with reduced disulfide bonds, samples 
of interest were diluted with 38 µl of SDS sample buffer (100 mM Tris-HCl pH 9.0/ 1% 
SDS) and 5 µl of β–mercaptoethanol.  The mixture was heated in a water bath at 100 oC 
for 3 minutes.  After cooling down in a room-temperature water bath for 5 minutes, the 
sample was injected for 20 seconds at 5 kV and separated for 30 minutes at 15 kV 
(reverse polarity), with 20 psi on both inlet and outlet.  Samples with non-reduced 
disulfide bonds were diluted with 38 µl of SDS sample buffer (100 mM Tris-HCl pH 9.0/ 
1% SDS) and 5 µl of 250 mM iodoacetamide solution.  The mixture was heated in a 
water bath at 70 oC for 3 minutes.  The capillary electrophoresis method used was for 
samples with reduced disulfide bonds. 
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CHAPTER III 
 
RESULTS 
Female Gametophyte Collection and Embryogenic Multiplication Bioassay 
Female gametophyte collection 
The female gametophyte (FG), also called megagametophyte or the embryo sac, 
is the ovule of one or more zygotic embryos in Gymnosperm seeds.  It contains a haploid 
number of chromosomes and provides nourishment to embryo development.  This pattern 
is different from angiosperm embryos, which have attached cotyledons as seed storage 
organs.  Figure 6 shows the anatomy of a loblolly pine seed. 
In LP SE, FG tissue is absent in the embryogenic tissue culture.  In culture, 
important compounds produced by FG such as vitamins are absent and need to be added 
as medium supplements.  
 
Effect of LP stage-specific FG water extracts on Bioassay 
Figure 7A exhibits the performance of early-stage somatic embryogenic 
multiplication bioassay.  Typically, a single early-stage embryo is on average 1.0 mm in 
diameter and will grow to form an embryogenic mass 5 to 9 mm in diameter in four to six 
weeks depending on the genotype of somatic embryo.  The typical duration for each 
genotype to continue multiplying in liquid culture is about one to two years.  However, 
some genotypes such as 500 survive longer.  The majority of bioassays in this 
dissertation were using genotype 500 as the early-stage somatic embryo.   
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Preliminary experiments were conducted to investigate the effect of LP stage-
specific FG tissue water extracts on early-stage somatic embryo growth.  Female 
gametophyte tissue collected in 1997 from tree UC5-1036 from stages 1, 2, 3, 4, 6, 8, 9.1, 
9.3, 9.5, 9.7 and 9.9 was water extracted and applied onto multiplication bioassay.  
Statistic analysis of bioassay results revealed that FG water extracts from stages 1, 2, 3, 
and 8 contain compound(s) that stimulate growth of early-stage somatic embryo 
(genotype 500) in a statistically significant manner at p = 0.05 compared to the control 
treatment without extract, whereas FG water extracts from stages 9.7 and 9.9 FG contain 
substance(s) inhibitory to early-stage somatic embryo growth, illustrated in Figure 7B.  
Further bioassay experiments were carried out using FG water extracts from stage 2 and 
9.12 of tree S4PT6 collected in 1997.  The results were identical to those from tree UC5-
1036, with stage 2 FG extract stimulatory and stage 9.12 FG extract inhibitory to the 
embryo growth in a statistically significant manner.       
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Figure 6.  Anatomy of loblolly pine seed. 
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Figure 7.  (A) Early-Stage Somatic Embryogenic Multiplication Bioassay.  (B) Water 
Extracts from Staged Female Gametophyte Tissue. 
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Liquid Chromatography Isolation and Identification 
Gel filtration chromatography I 
All Superdex (GE Healthcare, Piscataway, NJ) gel filtration columns are formed 
by the dextran chains covalently bonded to a highly cross-linked agarose gel matrix.  The 
first chromatography isolation step was achieved on a Superdex 75 gel filtration column 
which is designed for biomolecule separations from 3000 Da up to 600 kD (globular 
proteins). 
 
Eluent selection 
Plain water was originally used as the eluent.  However, water elution gave rise to 
inconsistencies in the bioassay and MS results, causing difficulties in tracking the 
inhibitory molecule.   
The eluent was then switched to 150 mM NaCl solution.  After the FG water 
extract was lyophilized to dryness, it was re-dissolved in 150 mM NaCl and centrifuged; 
the resulting supernatant was loaded on a Superdex 75 10/300 GL gel filtration column.  
Fractions were grouped and numbered according to the elution of each peak.  Each 
fraction was lyophilized and applied to the SE multiplication bioassay directly.  The 
bioassay results showed that all fractions eluted from the Superdex 75 column inhibited 
somatic embryo growth in a statistically significant manner at p = 0.05.  A later bioassay 
with salt control corresponding to the minimum and maximum amount of salt contained 
in each fraction was carried out, which revealed that even the lowest amount of salt could 
inhibit the embryo growth in a statistically significant manner.  These results suggest that 
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salt depletion is essential for the preciseness of the bioassay to identify the bioactive 
compound. 
 
Selection of desalting method  
Estimation of MW range of the active fraction F2 was based on calibration curve 
using four globular proteins, albumin, ovalbumin, chymotrypsinogen A and ribonuclease 
A.  Since F2 falls into the range of 9kD to 16kD, it is very likely that the active molecule 
is a small protein.  But the possibility of a small molecule which is associated with 
proteins with MW in that range could not be excluded.  Dialysis using membrane tubing 
(Spectra CE, Spectrum Laboratories, Rancho Dominguez, CA) with 100 Da cutoff was 
first used as the salt depletion method.  However, due to large fraction volume and large 
amount of salt collected from the Superdex 75 column, this method was not efficient to 
remove salt.  Alternative desalting was achieved by ultrafiltration with either an Amicon 
stirred cell containing an YM1 (1000 Da cutoff) membrane or a Centricon centrifugal 
device (3000 Da cutoff).   
Osmolality measurement was performed to correlate between the optimal 
ultrafiltration duration, number of times of water change and concentration of remaining 
salt in BSA solution.  According to Table 3, after three times of water change and six 
hours, the osmolality of the retentate was close to that of water, implying that these 
conditions were the optimal for desalting after the Superdex 75 column. 
 
Elution and bioassay 
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Consequently, fractions obtained were salt depleted by ultrafiltration (1000 Da 
cutoff).  Since the elution of gel filtration is isocratic, the time length of ultrafiltration is 
based on previous osmotic pressure measurement.  The retention time for each fraction is 
as follows: F1 from 15.08 to 27.00 min, F2 from 27.00 to 34.04 min, F3 from 34.04 to 
55.06 min, F4 from 59.07 to 77.08 min, as illustrated in Figure 8A.  The retentate of each 
fraction was lyophilized overnight to dryness.  Dry fractions obtained were re-dissolved 
with deionized water, pH adjusted at 5.7 and applied to bioassay.  The subsequent 
bioassay data is shown in Figure 8B.  F2 eluting from 27.00 min to 34.04 min was the 
only fraction which statistically significantly inhibited the embryo growth compared to 
the blank control.  The rest treatments exhibited similar embryo growth to that of the 
control.  
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Table 3.  Osmolality of pure water, filtrate and retentate after Centricon and Amicon 
membranes 
 
ID Osmolality (mM)
Osmolality 
(mM)
Osmolality 
(mM)
Ave
 (mM)
12.9mg BSA in 
150 mM NaCl 292 307 295 298
pure water 39 41 41 40.333
Centricon filtrate 
after 1st change 372 371 370 371
Centricon filtrate
 after 2nd change 102 110 116 109.33
Centricon filtrate 
after 3rd change 51 52 53 52
Centricon BSA retentate 47 45 44 45.333
Amicon filtrate 
after 1st change 57 65 59 60.333
Amicon filtrate 
after 2nd change 46 47 47 46.667
Amicon filtrate 
after 3rd change 42 43 46 43.667
Amicon BSA retentate 46 42 45 44.333
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Figure 8.  (A) Superdex 75 FPLC elution profile for the inhibitor 1st fractionation eluted 
with 150 mM NaCl, 280 nm.  (B) Bioassay of the fractions eluted from a Superdex 75 
column. 
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Calibration and Molecular Weight Estimations 
Four globular proteins, Ribonuclease A, Chymotrysinogen A, Ovalbumin and 
Albumin, packed in a low molecular weight gel filtration calibration kit, were used to 
calibrate the Superdex 75 column.  The molecular weight of the inhibitory fraction F2 
obtained from calibration curve of gel filtration column was to correlate with that 
acquired from mass spectrometry.  Figure 9 is the calibration elution profile of these four 
protein standards and Figure 10 shows the molecular weight calibration curve defining 
the relationship between the elution volumes of these standards and the logarithm of their 
respective molecular weights.  The void volume of the column was determined using 
Blue Dextran 2000.   
According to this calibration curve, the mass range of F2 was calculated spanning 
from 9kD to 16kD, whereas mass analysis of the purified inhibitory molecule was only 
660 Da, described in later mass spectrometry characterization.  This inconsistency was 
caused by co-elution of multiple proteins or peptides falling in this mass range with the 
inhibitory molecule from the gel filtration column, supported by the detection of various 
proteins in LC/MS spectra of the first two active fractions (F2 and F2-S1).        
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Figure 9. Superdex 75 FPLC Calibration Elution Profile monitored at 254 nm (blue) and 
280 nm (green). 
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150 mM NaCl Eluent 
8.22 mL Vo  23.56 mL Vt 
 15.34 mL Vt - Vo 
 
 
Concentration MW 
kDa (mg/ml) Protein Log(MW) Ve Kav 
7 64.7 1.810904 9.65 0.09322 Albumin 
7 45.8 1.660865 10.47 0.146675Ovalbumin 
3 19.9 1.298853 12.54 0.281617Chymotrypsinogen A 
10 15.4 1.187521 13.63 0.352673Ribonuclease A 
 
 
K =(Vav e-V )/(V -V0 t 0) 
Ve = elution volume for the protein  
V  = column void volume 0
Vt = total bed volume 
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Figure 10.  Molecular weight calibration curve of the Superdex 75 column. 
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Reversed Phase Chromatography 
The reversed phase columns used in attempts to separate F2 were the 
Phenomenex Jupiter C5 column (5 µm, 300 Å, 4.6×250 mm, Phenomenex, Torrance, 
CA), the Alltech ProSphere C18 column (5 µm, 300 Å, 4.6×150 mm, Alltech, Deerfield, 
IL) and the Vydac 218TP C18 column (3 µm, 300 Å, 1.0×250 mm, Vydac, Deerfield, 
IL).   
All above three reversed phase columns have wide pore size of 300 Å, which 
allows access of large proteins while still maintaining resolution of small peptides.  The 
Vydac 218 TP C18 column is a microbore column packed with polymerically bonded 
endcapped n-octadecyl reversed phase based on 300 Å TP silica.  Both methanol and 
acetonitrile were used as the organic modifier; TFA and formic acid were used as the ion 
pair reagent.  Various concentrations of ion pair reagents and various gradients were 
applied to adjust the retention of compounds on columns and the baseline separation.   
For the Vydac 218 TP C18 column, chromatogram with a single peak was 
obtained, with no indication of separation under these conditions.  Chromatograms of 
both the Phenomenex Jupiter C5 column and the Alltech ProSphere C18 column 
exhibited three distinct peaks, and the performance of the former was more consist than 
the latter; therefore, the Phenomenex Jupiter C5 column was consequently selected for 
further separation of F2 and for the subsequent bioassay as well.  All fractions were 
manually collected and retention times are: P1, 2.5 to 6.0 min, P2, 16.0 to 22.4 min, P3, 
22.4 to 26.0 min (Figure 11A).  However, several later bioassays did not show any 
inhibitory bioactivity from any subfraction.  Figure 11B shows the result of one of the 
bioassays.  The F2 control from the Superdex 75 column consistently inhibited the early-
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stage somatic embryo growth in a statistically significant manner, whereas treatments of 
all subfractions and the mixture of subfraction P2 and P3 (labeled P23) did not affect the 
embryo growth compared to the blank control.  This result showed that the inhibitory 
bioactivity could not be recaptured from this elution condition.  
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Figure 11.  (A) Phenomenex Jupiter C5 RP HPLC elution profile for the subfractionation 
of F2, 215 nm. (B) Bioassay of the HPLC-isolated fractions eluted from a Phenomenex 
Jupiter C5 RP column. 
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Hydrophobic Interaction Chromatography (HIC) 
Many theories based on interactions between hydrophobic solutes and water have 
been proposed regarding HIC (Tanfor and sons, 1973; Creighton and Freeman, 1984), but 
none of them have been universally accepted.  Only the central role played by the 
structure-forming salts is common to these theories: the structure-forming salts affect the 
individual components (i.e., solute, solvent and adsorbent) of the chromatographic system 
to bring about the binding of solute to adsorbent (Porath, 1986).  One of the most 
acceptable theories is that close to the surface of the hydrophobic ligand attached to 
polymer matrix and solute molecules, water molecules are more highly ordered than in 
the bulk water, resulting in shielding off the hydrophobic ligand and solute molecules.  
Salt added in the eluent interacts strongly with water molecules and leaves less water 
available for the shielding off effect, which is the driving force for hydrophobic ligand 
and hydrophobic patch on surface of solute molecules to interact with each other (Hjertén, 
1977). 
There are several main factors affecting HIC, including type of ligand and degree 
of substitution, type of base matrix, type and concentration of salt, pH effect, temperature 
effect, and additives (Jennissen and Heilmeyer, 1975; Visser and Strating, 1975; 
Srinivasan and Ruckenstein, 1980; Hjertén et al., 1986; Narhi et al., 1989).   
The commercially available HIC media include butyl, octyl, phenyl groups linked 
to the glycidyl ether group.  This coupling procedure generates gels of free charge and 
having interactions with proteins only.  
 
Selection of column, eluent and gradient 
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Three HIC columns were used in attempt to improve the retention of compounds 
on them, including the HiPrep Butyl FF (-O-CH2-CHOH-CH2-O-(CH2)3- CH3) column, 
the HiPrep Phenyl FF (-O-CH2-CHOH-CH2-O-C6H6) column and the HiPrep Octyl FF (-
O-CH2-CHOH-CH2-O-(CH2)7-CH3) column.  Ammonium sulfate was chosen as the salt 
in eluent A due to its high precipitation effect.  Increased amount of ammonium sulfate 
was added up to 1.5 M, but for both Phenyl and Octyl HIC columns, chromatograms only 
exhibited a single peak before the start of gradient.  Sodium phosphate and sodium 
acetate buffers at pH ranging from 2.5 to 7.0 were also attempted to adjust the retention.  
Only the Butyl column can retain the F2 fraction under the condition of eluent A, 50 mM 
sodium phosphate buffer containing 1.5 M ammonium sulfate and eluent B, 50 mM 
sodium phosphate buffer, both at pH 2.5.  Various gradients were attempted to achieve 
the baseline separation and shortest time consumption.  A four-segment stepwise gradient 
was chosen as described in experimental procedure. 
   
Elution and desalting 
Fractions were pooled and collected as follows: F21, 2.57 to 14.67 min; F22, 
14.67 to 34.82 min; F23, 34.82 to 38.40 min; F24, 38.40 to 41.40 min, as shown in 
Figure 12A.  YM1 membrane continued to be used as the desalting procedure at first, but 
it was replaced by YM3 (3000 Da cutoff) membrane due to its high efficiency to 
ultrafiltrate high amount of salt.  Osmolality was measured to ensure the completeness of 
salt depletion from each fraction. 
 
Bioassay 
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Three bioassays were carried out, but none of them were consistent to each other.  
Figure 12B shows the best result for this HIC separation.  Both subfraction F22 and F23 
inhibited embryo growth in a statistically significant manner, but only inhibition from 
F22 was more statistically significant than that from the F2 control (F20) from the 
Superdex75 column.  However, in the later two bioassays, either F22 did not inhibit 
embryo growth in a statistically significant manner, or the subfraction F21 also inhibited 
embryo growth.  The bioassay result in Figure 12B was not reproducible.  Due to 
inconsistency in bioassay results from this elution condition and requirement of use of 
huge amount of salt for HIC columns, an alternative sub-fractionation procedure of F2 
was needed. 
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Figure 12.  (A) HiPrep 16/10 Butyl FF HIC FPLC elution profile for the subfractionation 
of F2, 215 nm.  (B) Bioassay of the FPLC-isolated fractions eluted from a HiPrep 16/10 
Butyl FF HIC column. 
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Ion Exchange Chromatography 
The definition of strong and weak ion exchangers is based on the extent of 
variation of ionization with pH, not the strength of binding.  Strong ion exchangers are 
characterized by complete ionization over a wide pH range; as for weak ion exchangers, 
the degree of dissociation and exchange capacity changes remarkably with pH.  
Sulphonic and quaternary amino groups are used to generate strong ion exchangers, 
whereas diethylaminoethyl (DEAE) and carboxymethyl (CM) groups form weak ion 
exchangers.  Compared with the weak ion exchangers, strong ion exchangers have 
several advantages, including stable loading capacity, simple mechanism of interaction 
and easiness of control. 
 
Strong cation exchange chromatography   
Consequently, the column selected for the second isolation chromatography is 
Mono S.  The cation exchanger of Mono S column is mehtyl sulphonate (-O-CH2-
CHOH-CH2-O-CH2-CHOH-CH2SO3-).   
 
Selection of eluent and gradient.  50 mM sodium formate at pH 3.75 was 
attempted to use as the buffer for the Mono S column.  Formate buffer itself has high UV 
absorbance during the wavelengths below 300 nm.   This resulted in limited detection in 
that sample peaks were not distinct enough to be distinguished from the baseline.  Lower 
pH can facilitate compounds retention to cation exchange columns.  Eluent A, 20 mM 
sodium phosphate buffer at pH 2.5, and eluent B, eluent A containing 2 M NaCl, were 
consequently used.  Various gradients were attempted to achieve the baseline separation 
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and shortest time consumption.  A four-segment stepwise gradient was chosen as 
described in experimental procedure. 
 
Elution and Desalting.  Fractions were pooled and grouped as follows: 
F2-S1: 0.68 to 2.02 min, F2-S2: 2.02 to 3.37 min, F2-S3: 13.29 to 21.30 min, F2-S4: 
21.30 to 27.30 min, F2-S5: 37.54 to 41.53 min (Figure 13A).  Desalting for each fraction 
was accomplished by an Amicon stirred cell containing an YM1 (1000 Da cutoff) 
membrane.  The duration of ultrafiltration applied to each fraction varied depending on 
the calculated salt amount it contained from the salt elution gradient.  Retentate was 
divided into aliquots and lyophilized to dryness.  
 
Bioassay.  Dry fractions were re-dissolved with 2ml of deionized water, pH 
adjusted at 5.7 and applied to bioassay.  F2-S1 eluting during the wash of unbound 
compounds was the only fraction which showed statistically significant inhibition to 
embryo growth compared to the blank control, in exactly the same manner as that of the 
F2 control from the Superdex75 column (Figure 13B), indicating that the active molecule 
is highly anionic and can not be retained on a strong cation exchange column.  F2-S2 and 
F2-S3 were weakly inhibitory to the growth, but not in a statistically significant manner.  
F2-S4 and F2-S5 treatments exhibited similar embryo growth to that of the blank control. 
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Figure 13.  (A) Mono S FPLC elution profile for the inhibitor 2nd fractionation eluted 
with 20 mM sodium phosphate buffer at pH 2.5, 215 nm.  (B) Bioassay of the fractions 
eluted from a Mono S column. 
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Strong anion exchange chromatography
The incapability of the active compound to bind to a Mono S column indicated 
that this compound is very anionic.  A strong anion exchange column, Mini Q, is selected 
for the third-step chromatography isolation.  Mini Q is composed of monodisperse 3 µm 
nonporous beads coupled to the anion exchanger, quaternary ammonium (-O-CH2-
CHOH-CH2-O-CH2-CHOH-CH2-N+(CH3)3).  The nonporous matrix of Minibeads offers 
improved resolution and separation for analytical scale.   
 A four-segment gradient was applied to accomplish the baseline separation.  
Retention time of each fraction is listed as follows: F2-S1-Q1, 2.10 to 6.05 min; F2-S1-
Q2, 6.05 to 11.12 min; F2-S1-Q3, 25.38 to 30.37 min; F2-S1-Q4, 30.37 to 36.34 min; F2-
S1-Q5, 36.34 to 43.34 min; F2-S1-Q6, 49.38 to 58.32 min (Figure 14A). 
All the resulting fractions were also processed desalting against YM3 membrane 
(3000 Da cutoff).   20 FG aliquot of each fraction was applied to the bioassay, which 
included treatments of blank control, active control from the previous Mono S column 
(F2-S1), all individual fractions from Mini Q and one combination of F2-S1-Q4 and F2-
S1-Q5.  The bioassay results (Figure 14B) revealed that both F2-S1-Q5 and F2-S1-Q6 
had the statistically significant inhibition to the embryo growth compared to the blank 
control.  However, the significance of inhibition was not as great as that of F2-S1 control.  
Treatment of the combination of F2-S1-Q4 and F2-S1-Q5 exhibited similar statistical 
significance of inhibition as that of F2-S1-Q5 alone, whereas F2-S1-Q4 alone did not 
inhibit embryo growth.  Neither did the remaining fractions from Mini Q, indicating F2-
S1-Q5 and F2-S1-Q6 were the only two inhibitory fractions.  However, collection of F2-
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S1-Q6 as two individual fractions based on the split of the peak did not retain any 
inhibitory bioactivity (data not shown).  
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Figure 14.  (A) Mini Q FPLC Elution profile for the inhibitor 3rd fractionation eluted 
with 20 mM Tris-Cl buffer at pH 8.0, 215 nm.  (B) Bioassay of the fractions eluted from 
a Mini Q column. 
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Weak anion exchange chromatography   
The weak anion exchanger DEAE is the abbreviation for diethylaminoethyl (-O-
CH2-CH2-N+H(CH2CH3)2).  The DEAE column was attempted to fractionate F2 for the 
second column separation after the Superdex 75.  Tris and bis-Tris buffers were used at 
various pH values ranging from 6.5 to 7.7 to adjust ionization of compounds with pH.  
Various gradients and concentrations of sodium chloride were applied to adjust the 
resolution of the separation and the retention of compounds on the column.  However, 
chromatograms with a single peak were obtained, indicative of no separation.  Or, 
chromatograms of blank runs showed inconsistently unknown peaks.  Therefore, this 
column was consequently abandoned. 
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Gel filtration chromatography II 
Column selection 
The weaker inhibition of Q5 and Q6 compared to that of the F2-S1 control and 
the absence of molecules above 1000 Da in both Q5 and Q6 indicated that the 3000 Da 
cutoff ultrafiltration membrane might not retain molecules of a lower molecular weight 
and a portion of the active molecule might have lost during the process.   Besides 
separation according to size, gel filtration columns are sometimes used as the final step in 
isolations, in that they can separate contaminants such as salt carried over from previous 
chromatography.  Superdex 75 was used in attempts to desalt and separate other small 
molecules from the active one.  Unfortunately, the subsequent MS results revealed a 
mixture of small molecules below 1000 Da in the subfraction in which the candidate 
active molecule is.  Therefore, a Superdex Peptide column was selected as the alternative 
desalting procedure.  This column is the only gel filtration column commercially 
available offering high-resolution separation of small biomolecules in the fractionation 
range of 100-7000 Da.   
 
Elution 
A volatile buffer such as ammonium acetate would be an ideal eluent, in that the 
Superdex Peptide column was selected mainly for desalting, and residual buffer salts 
would suppress ionization in subsequent MS characterization and mask the bioassay 
results by generating extra inhibition to embryo growth.  Flow rate was decreased from 
0.5 ml/min (lower value in the room temperature recommended by the manufacturer) to 
0.2 ml/min to adjust the resolution of the separation.  Fractions were pooled and grouped 
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based on absorbance at both 215 nm and 280 nm.  Elution times of each fraction are 
shown in Figure 15A: F2-S1-Q6-D1A, 62.06 to 80.14 min; F2-S1-Q6-D1B, 80.14 to 
90.13 min; F2-S1-Q6-D2, 90.13 to 95.06 min; F2-S1-Q6-D3, 95.06 to 98.12 min; F2-S1-
Q6-D4, 98.12 to 100.11 min.  Components eluting after D4 were Tris-Cl buffer, NaCl 
from the Mini Q column and water peak, supported by individual control runs with 
injections of corresponding amount of each of them.  Additionally, conductivity recorded 
on-line with UV detection also indicated the retention times of Tris-Cl and NaCl elution.   
 
Bioassay 
Treatments in this bioassay included:  
• a blank control; 
• bioactive control fractions F2-S1 and F2-S1-Q6-YM3 (from the Mini Q 
column followed by desalting against YM3 ultrafiltration membrane, labeled 
as Q6-YM3); 
• buffer control (6ml of 100mM ammonium acetate lyophilized to dryness, 
corresponding to the highest amount of ammonium acetate contained in 
treatments before lyophilization), labeled as NH4Ac; 
• all individual fractions from the Superdex Peptide column, labeled as Q6-D1A, 
Q6-D1B, Q6-D2, Q6-D3 and Q6-D4; 
• one combination of F2-S1-Q6-D1A and F2-S1-Q6-D1B, labeled as Q6-D1. 
Figure 15B shows the bioassay results of the fractions eluted from a Superdex 
Peptide column.  F2-S1-Q6-D1B and F2-S1-Q6-D1 are the most statistically significant 
inhibitory treatments of this set of bioassay.  Active control fractions F2-S1 and F2-S1-
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Q6-YM3 along with subfraction F2-S1-Q6-D2 also exhibited statistically significant 
inhibition to the embryo growth, but much less inhibitory than F2-S1-Q6-D1B and F2-
S1-Q6-D1. 
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Figure 15.  (A) Superdex Peptide FPLC elution profile for the inhibitor 4th fractionation 
eluted with 100 mM ammonium acetate buffer at pH 5.5, 215 and 280 nm.  (B) Bioassay 
of the fractions eluted from a Superdex Peptide column. 
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Figure 16.  Final flow chart of isolation and characterization of InsP  from FG tissue. 6
  76
Scale-up collection 
Scale-up collection of the final active fraction F2-S1-Q6-D1B for NMR and MS 
analyses required 800 full-term dry seeds from tree S4PT6 of year 2006.  Each seed was 
cracked open and the FG tissue was collected and water extracted within three days.  
Every step of purification conformed to the protocol shown in the flow chart (Figure 16).  
800 FG was divided evenly into two batches, and each batch was performed sequentially.  
The amount of FG loaded onto each column was adjusted higher within the column 
capacity than previous analytical collections to improve scale-up efficiency.  Fresh FG, 
lyophilized water extract, aliquots of lyophilized active fractions from Superdex 75 
(ultrafiltered against YM1 membrane), Mono S (ultrafiltered against YM1 membrane) 
and Superdex Peptide columns were weighed out and yield was calculated in Table 4.  
F2-S1-Q6 directly from the Mini Q column was not included in the yield calculation due 
to high concentration of NaCl involved in this fraction.   
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Table 4.  Yield of active fractions from successive processing steps. 
 
 
 
FG and sequential 
active fractions 
Number 
of FG 
weighed 
Weight  
(mg) 
Number of 
Normalized 
FG 
Normalized 
Weight 
(mg) 
Yield  
Fresh FG collected 
from dry seed 60 812.5 100 1354.17 --- 
Lyophilized FG 
water extract 50 37.05 100 74.10 5.5×10
-2
Lyophilized F2 50 4.55 100 9.10 6.7×10-3
Lyophilized F2-S1 100 1.32 100 1.32 9.7×10-4
Lyophilized F2-S1-
Q6-D1B 100 0.11 100 0.11 8.1×10
-5
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Mass Spectrometry Characterization 
LC/MS  
LC/MS positive polarity 
Instrument overview.  Atmospheric pressure ionization (API) mass spectrometry 
(MS), particularly electrospray ionization (ESI), allows the analysis of thermolabile 
compounds of low molecular mass.  The Applied Biosystems/MDS SCIEX 4000 
QTRAPTM LC/MS/MS system is a combination of a triple quadrupole MS and linear ion 
trap (LIT) technology.  The ion path of this system is identical to that of a standard triple 
quadrupole with a series of four rod quadrupoles.  The final quadrupole, Q3, can be 
operated either in the normal RF/DC (quadrupole) mode or in LIT mode in a mass-
selective fashion.  Figure 17 shows a schematic ion path of QTRAP.  
In the LIT mode, ions generated at atmospheric pressure flow through the orifice 
and skimmer regions, through the milli-torr pressure Q0 ion guide, through Q1 also 
operated as an ion guide, through the pressurized Q2 collision cell, and into the Q3 LIT.  
Ions are trapped in Q3 by the RF voltage operating in the radial direction and by the DC-
biased aperture plates operating in the axial direction.  After the trapped ions are cooled 
briefly, they are scanned out of Q3 in an axial direction toward the ion detector to yield a 
high sensitivity survey MS scan, named enhanced mass spectrometry (EMS) scan (Le 
Blanc et al., 2003; Hopfgartner et al., 2004) 
LC/MS analyses under positive polarity of the fractions from the Superdex 75, 
Mono S and Mini Q columns were performed with quadrupole scans.  LC/MS analyses of 
fractions from the Superdex Peptide column and analyses of F2-S1-Q6 before 
LC/MS/MS of the m/z 661 precursor ion under positive polarity were carried out with 
  79
EMS scans.  No difference in either resolution or sensitivity between the Q1 and Q3 
quadrupoles was observed when operating Q3 in either the RF/DC mode or the LIT mode. 
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Figure 17.  A schematic representation of the ion path of the QTRAP instrument, 
modified from (Le Blanc et al., 2003).  Q1 is a standard RF/DC quadrupole mass filter; 
the final quadrupole, Q3, can be operated either in the normal RF/DC (quadrupole) mode 
or in linear ion trap mode. 
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Selection of column and mobile phase.  Several reversed phase columns were 
used for LC/MS in attempts to characterize F2.  The columns tried were the Discovery 
C5 Bio Wide Pore column (5 µm, 300 Å, 3.2×150 mm, Supelco, Bellefonte, PA), the 
Discovery C18 Bio Wide Pore column (5 µm, 300 Å, 3.2×150 mm, Supelco, Bellefonte, 
PA), the polymer-based monolithic PS column (200 µm ×50 mm, Dionex, Sunnyvale, 
CA), the Agilent Hypersil ODS amino acid column (2.3×200 mm, Foster City, CA), the 
C18 PepMap capillary column (3 µm, 100 Å, 0.3×250 mm, Dionex, Sunnyvale, CA) 
and the Vydac C8 capillary column (5µ, 300 Å, 0.3×250 mm, Deerfield, IL).  Among 
them, the Vydac C8 capillary column packed with 5µm particles with 300 Å pore size 
exhibited the best performance based on separation and consistency, and was 
consequently selected. 
TFA and formic acid can both serve as ion pair reagents, but TFA suppresses the 
ESI signals of analytes due to its ability to form gas-phase ion pairs with positively-
charged analyte ions (Kuhlmann et al., 1995).  Therefore, formic acid was included in the 
mobile phase.  In terms of the organic modifier, acetonitrile showed stronger retention of 
the F2 fraction on columns than methanol.  The consequent mobile phase A was 
comprised of 2% acetonitrile, 98% water and mobile phase B was 80% acetonitrile, 20% 
water, both containing 0.1% formic acid. 
 
 
LC/MS of active fractions.  LC/MS of F2, the active fraction collected from the 
Superdex 75 column and ultrafiltered against a YM3 membrane exhibited a mixture of 
singly charged and hundreds of multiply charged ions, indicating that the active F2 
fraction contained various proteins as well as small molecules (Figure 18).  Mass spectra 
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at different retention times revealed that the ion at m/z 661 was co-eluting with various 
multiply charged ions.  An extracted ion chromatogram (XIC) of ion at m/z 661 
confirmed that it eluted over the entire time course (data not shown).   
F2-S1, the active fraction collected from the Mono S column (ultrafiltered against 
a YM3 membrane), only contained three peptides, the deconvoluted masses of which are 
2649, 2102 and 2426 Da.  The m/z 661 molecule co-eluted with peptides of 2649 and 
2102 Da (Figure 19).  XIC of ion at m/z 661 revealed that the majority of this molecule 
eluted from four to ten min, where most unbound molecules such as salt and plasticizer 
contaminants elute, whereas some of this ion was retained on the column up to 
approximately 40 min.   
LC/MS of F2-S1-Q6, the active fraction collected from Mini Q (ultrafiltered 
against a YM3 membrane), exhibited one distinct ion at m/z 661 and a polymer 
plasticizer co-eluting with this ion near the void volume (Figure 20), as well as a number 
of species of low molecular mass at different retention times.  The lack of multiply 
charged ions suggests that the inhibitory molecule is unlikely to be a polypeptide.  
Among several LC/MS runs of F2-S1-Q6, only one of them showed retention of the ion 
at m/z 661 from 26.6 to 29.7 min, and the rest exhibited its elution near the void volume.  
An array of sodium adduct ions with mass difference of 22 amu (the mass difference 
between sodium Na+ and proton H+) were observed downstream of the ion at m/z 661.  
However, the number of sodium adduct ions varied through the elution.  From 26.6 to 
29.7 min, a maximum of eight sodium adduct ions, corresponding to the +1 (Na+), +2 
(Na+), and up to +8 (Na+) salts of the species at m/z 661, were observed, whereas only 
two to six sodium adduct ions showed near the void.  In the other active fraction from the 
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Mini Q, F2-S1-Q5, the ion at m/z 661 was also present (data not shown).  But for the 
remaining inactive fractions F2-S1-Q1 through F2-S1-Q4, no such ion was detected in 
their mass spectra.  These results indicated that the ion at m/z 661 corresponds to the 
active molecule to be pursued. 
In the LC/MS run of F2-S1-Q6-D1B (Figure 21), the active fraction from the 
Superdex Peptide column, only the ion at m/z 661 and its three sodium adduct ions were 
present, suggesting that the improved desalting procedure using the Superdex Peptide 
column removed plasticizers and other small molecules, and isolated the pure compound.   
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Figure 18. Total ion chromatogram and MS spectra of F2 (the active fraction from Superdex 75). 
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Figure 19. Total ion chromatogram and MS spectra of F2-S1 (the active fraction from Mono S). 
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Figure 20. Total ion chromatogram and MS spectra of F2-S1-Q6 (the active fraction from Mini Q, desalted by 3000 Da cutoff 
membrane). 
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Figure 21.  Total ion chromatogram and MS spectrum of F2-S1-Q6-D1B (the active fraction from Superdex Peptide column). 
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LC-MS negative polarity 
Two different LC approaches for the LC/MS characterization under negative 
quadrupole scan mode of all fractions from the Mini Q column were accomplished using 
either a Phenomenex C5 analytical column or a Vydac C8 capillary column.  Elutions 
were performed at pH 5.5 and pH 7.0, respectively.  LC/MS results from both LC 
approaches were identical to those obtained from the positive scans.  The corresponding 
ion at m/z 659 was only detected in the active fractions F2-S1-Q5 and F2-S1-Q6, but not 
in any of the other inactive fractions (data not shown).  No multiply charged ions were 
observed in F2-S1-Q5 and F2-S1-Q6, suggesting that the inhibitory molecule is unlikely 
to be a polypeptide or nucleic acid.  These results confirmed that ion at m/z 659 
corresponds to the active molecule to be pursued.   The m/z difference of 2 amu between 
ion at m/z 661 from the positive scan and ion at m/z 659 from the negative scan indicated 
that both ions are singly charged and the average mass of this molecule is 660 Da.   
 
  89
Exact Mass Analysis 
Instrument overview 
The inhibitory molecule was originally postulated to be a plant peptide hormone.  
The Applied Biosystems QSTAR XL Hybrid LC/MS system was selected for LC/MS 
analyses due to its sensitivity for the identification and characterization of low-abundance 
proteins.  QSTAR is a hybrid quadrupole time-of-flight mass (TOF) spectrometer.  The 
quadrupole analyzer allows high transmission and high scan speeds, and TOF offers a 
broad mass scan range up to 40,000 m/z as well as exact mass measurement down to ± 
0.0001 ppm, which is perfect for protein database searching.    After all LC/MS analyses 
were transferred to the QTRAP instrument, QSTAR was used only for exact mass 
measurement and the subsequent tandem MS analysis. 
 
Exact Mass Analysis under positive polarity
Due to the limited amount of FG available to acquire NMR spectra of the active 
fraction, an exact mass measurement under positive polarity of F2-S1-Q6 (desalted 
against a YM3 membrane) was carried out to generate empirical formulas of candidate 
molecules to investigate the possible structure.  F2-S1-Q6 showed an exact mass (M+H)+ 
of 660.8476.  The (M+2H)2+ and (M+3H)3+ ions constituted 7.30 % and 6.12 % relative 
intensities of (M+H)+, respectively.  This result indicated that the maximum number of 
carbon atoms included in this molecule would not exceed ten, since the natural 
abundance of 13C is 1.11% and the (M+2H)2+ ion of a molecule containing ten carbons 
constitutes 11.1% relative intensitiy of (M+H)+.  This percentage is already 3.8% higher 
than the observed 7.3% without contributions from other elements.  Additionally, silicon, 
  90
sulfur, chlorine and bromine are unlikely to be present, due to their high M+2 peaks.  
Phosphorus is monoisotopic and known for its presence in many biomolecules, therefore, 
it is very likely to be one of the elements.  Nitrogen is also known to be one common 
element in natural products and it only contributes 0.38% to the M+1 peak.  The 
involvement of iodine and fluorine could not be completely excluded, in that they are 
also monoisotopic elements.  Nevertheless, iodine and fluorine are not very common 
elements in biomolecules.  Therefore, the elements were likely to be a combination of 
carbon (1-10), hydrogen (0-30), oxygen (0-30), nitrogen (0-10) and phosphorus (0-8).  A 
list of 130 candidate formulas was generated under the error tolerance of ±30 ppm.   
Formulas with either unreasonable elemental combinations or unreasonable 
relative intensities of isotope peaks were excluded.  The remaining 14 formulas were 
submitted to a database search, including CAS registry (Scifinder), SDBS (spectral 
database of organic compounds from Japan), and the NIST library (National Institute for 
Standards and Technology).  None of the formulas were found to have a match in any of 
these three databases.  Possible structures were hypothesized based on both candidate 
empirical formulas and the LC/MS/MS spectra under positive polarity.  However, none 
of the structures were feasible. 
 
Exact Mass Analysis under negative polarity
After the TriVersaTM NanoMate (Advion, Ithaca, NY) was installed on QSTAR, 
the sensitivity of the instrument was comparable to that of the QTRAP down to the fmol 
level.  The NanoMate combines the strengths of LC, fraction collection and chip-based 
infusion in one integrated system.  The ESI microfluidics chip contains an array of 
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nanoelectrospray nozzles, each one-fifth the diameter of a human hair, etched in a silicon 
wafer.  The unique field strength created by the nanoelectrospray nozzles allows for a 
more efficient and stable spray (Figure 22A).  As shown in Figure 22B, LC/MS is 
performed while simultaneously collecting fractions in a 96/384 well sample plate and 
software links the chromatographic peaks with collected fractions in the sample plate; a 
robot picks up one pipette tip from the rack; moves the tip to the 96/384 well sample 
plate and the target fraction is aspirated; the tip with the targeted sample then engages to 
the back of the ESI chip; the targeted fraction is infused and ions spray into the mass 
spectrometer.  The long infusion times allow signal averaging for increased sensitivity 
(Advion).    
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Figure 22.  (A) ESI nanochip.  (B) Schematic presentation of LC/MS coupled to 
NanoMate.
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Structural characterization of F2-S1-Q6-D1B using NMR (described in NMR 
characterization) suggests that the inhibitory molecule is InsP6.  Therefore, exact mass 
measurements and subsequent tandem MS analyses of both F2-S1-Q6-D1B and the 
commercial InsP6 were carried out on the new system under negative polarity to 
investigate the identity of the inhibitory molecule.  As shown in the Figure 26 inset, F2-
S1-Q6-D1B exhibited an exact mass (M-H)- of 658.8506 with an error of negative 5.3 
ppm with respect to the calculated molecular mass of 658.8541, and the commercial 
InsP6 showed an exact mass (M-H)- of 658. 8563 with an accuracy of 3.3 ppm, as shown 
in Figure 27 inset.   
 
MS/MS 
LC-MS/MS positive polarity
The LC/MS/MS spectra of the precursor ion at m/z 661 (obtained from F2-S1-Q6 
ultrafiltered against a YM3 membrane) under positive polarity were acquired subsequent 
to LC/MS on QTRAP.  Enhanced product ion (EPI) scans were performed subsequent to 
the EMS scan.  In the EPI scan, the selection of the precursor ion is achieved in Q1 
utilizing RF/DC isolation.  The selected precursor ion is accelerated into a pressurized 
transmission collision cell to induce fragmentation.  The ions emerging from Q2 are 
trapped in the Q3 LIT and subsequently mass selectively scanned out of the trap toward 
the ion detector (Hager and Yves Le Blanc, 2003; Hopfgartner et al., 2004). 
The precursor ion (M+H)+ at m/z 661 was subjected to collision energies of 40 
and 80 eV, respectively.  Figure 23 inset shows the MS/MS spectrum of the (M+H)+ at 
m/z 661 obtained at 40 eV.  The protonated ion at m/z 661 yielded a series of prominent 
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ions at m/z 643, 625, 607, 581, 563, 545, 527, 483, 465, 447, 429, 385, 367, 349, 287, 
269, 259, 189, 179, 161, 99.  After the inhibitory molecule was identified as InsP6 by 
NMR, exact MS and MS/MS analyses under negative polarity, the cause of the 
generation of fragment ions under positive polarity could be explained by successive 
losses of H2O (18 amu), HPO3 (80 amu), or H3PO4 (98 amu).  However, some fragment 
ions arose from multiple pathways, as shown in Figure 25.   For example, the ion at m/z 
367 can be formed not only from the ion at m/z 465 via loss of H3PO4, but from the ion at 
m/z 447 via loss of HPO3 as well.  Additionally, elimination of H2O from the ion at m/z 
385 can also generate the m/z 367 ion.  Ions at m/z 259, 241, 179, 81 were due to further 
loss of CO from ions at m/z 287, 269, 207, and 109, respectively.   
  Figure 24 inset shows the MS/MS spectrum of the (M+H)+ at m/z 661 obtained 
at 80 eV.  Further dissociation intensified the low m/z fragment ions, whereas the 
abundances of the high m/z fragment ions decreased tremendously.  Ions higher than m/z 
447 were not observed.  XIC of major fragment ions under both collision energies 
exhibited identical trace pattern as that of TIC of the precursor ion, suggesting that only 
one isomeric form was present in the precursor ion (M+H)+ at m/z 661.     
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Figure 23.  TIC and LC/MS/MS spectrum on precursor ion 661 from F2-S1-Q6 (the active fraction from Mini Q, desalted by 3000 
Da cutoff membrane) at CE 40 eV. 
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Figure 24.  TIC and LC/MS/MS spectrum on precursor ion 661 from F2-S1-Q6 (the active fraction from Mini Q, desalted by 3000 
Da cutoff membrane) at CE 80 eV. 
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Figure 25.  A schematic presentation of fragmentation pathways in LC/MS/MS under positive polarity, modified from (Hsu et al., 
2003) 
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MS/MS negative polarity 
Tandem mass spectra of the precursor ion at m/z 659 obtained from F2-S1-Q6-
D1B and the commercial InsP6 under negative polarity were acquired subsequent to the 
exact mass measurement on the QSTAR interfaced with NanoMate.  Two collision 
energies of 40 and 80 eV were applied to the precursor ion (M-H)- at m/z 659, 
respectively.  Spectra of F2-S1-Q6-D1B (Figures 26 and 28A) and the commercial InsP6 
(Figures 27 and 28B) under both collision energies were identical.  Furthermore, MS/MS 
spectra acquired under negative polarity were consistent with those from positive mode, 
with each fragment ion lower by 2 amu.  These results suggest that the pure inhibitory 
molecule is InsP6 or one of its isomers.  
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Figure 26.  MS/MS on molecular ion 659 from full-term dry seed and exact MS of F2-S1-Q6-D1B (the active fraction from Superdex 
Peptide column) at CE 40 eV in negative polarity. 
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 standard from Chromadex at CE 40 eV in negative polarity.Figure 27.  MS/MS on molecular ion 659 and exact MS of InsP6
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Figure 28. (A) MS/MS on molecular ion 659 of F2-S1-Q6-D1B (the active fraction from 
the Superdex Peptide column); (B) MS/MS on molecular ion 659 of InsP6 standard from 
Chromadex, both at CE 80 eV in negative polarity. 
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NMR Characterization 
One-dimensional NMR 
The 13C NMR spectra of F2-S1-Q6-D1B (Figure 32 bottom panel) revealed four 
distinct peaks at 77.40, 75.89, 74.51 and 73.39 ppm with an intensity ratio of 1:2:1:2, 
suggesting six carbons with two independent pairs of equivalent carbons and two non-
equivalent individual carbons.  Similar patterns were observed in both 1H NMR (four 
distinct peaks at 4.59, 4.09, 3.82 and 3.76 ppm with an intensity ratio of 1:2:1:2, Figure 
30 top panel) and 31P NMR (four distinct peaks at 2.54, 2.29, 2.06 and 1.63 ppm with an 
intensity ratio of 1:2:1:2, Figure 31 top panel) spectra of F2-S1-Q6-D1B.  A database 
search within SDBS based on 13C NMR spectra found one match as myo-inositol.  All 
these results suggest that the inhibitory molecule is an organophosphorus compound 
containing six phosphates, each directly linked to a (-CH) group of myo-inositol. 
To confirm that the inhibitory molecule is indeed InsP6, commercially available 
InsP6 was used to obtain both 1-D and 2-D NMR spectra.  The 1H NMR, 31P NMR and 
13C NMR spectra of both F2-S1-Q6-D1B and the commercial InsP6 are presented in 
Figure 30, 31, 32, respectively.  The pH of F2-S1-Q6-D1B was measured at 8.22 and all 
its spectra were recorded at this value.  The commercial InsP6 was prepared from its 
dodecasodium salt through cation exchange resin and the pH adjusted to the same value 
using NaOD, in order to circumvent the generation of extra NaCl.  The 1H chemical shift 
assignments were made according to Murthy et al (Bauman et al., 1999).  The Chemical 
structure of InsP6 is shown in Figure 29 with six carbons labeled.  Assignments of 13C 
and 31P resonances were made from a 2D 1H-13C HSQC (Figure 35) and a 2D 1H-31P 
HSQC (Figure 37), respectively.  Both chemical shifts and splitting patterns of F2-S1-
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Q6-D1B are identical to those of the commercial InsP6, suggesting that the inhibitory 
molecule in F2-S1-Q6-D1B is InsP6.  The chemical shift assignments and coupling 
constants are listed in Table 5-7.   
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Figure 29.  Chemical structure of InsP .  6
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Table 5.  1H chemical shift assignments and coupling constants of F2-S1-Q6-D1B and 
commercial InsP6. 
1H  
Proton 
Position
 Chemical 
Shift 
Integration Multiplicity J (Hz) 
4.59 2 1 d J2-P1 (8.803) 
4.09 4/6 2 q J  (9.048) 4/6-5
F2-S1- 
3.82 5 1 m J  (9.048) 4/6-5
Q6-D1B 
J  (8.314) 3-4
3.76 1/3 2 t 
J  (8.314) 1-6
4.56 2 1 d J2-P1 (9.048) 
4.08 4/6 2 q J  (9.537) 4/6-5
Commercial 
InsP
3.79 5 1 m J  (9.537) 4/6-5
6
J  (8.803) 3-4
3.74 1/3 2 t 
J  (8.803) 1-6
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Table 6.  31P chemical shift assignments of F2-S1-Q6-D1B and commercial InsP . 6
 
 
 
31P  
Phosphate 
Position 
 Chemical 
Shift 
Integration Multiplicity
2.54 5 1 s 
2.29 1/3 2 s F2-S1- 
Q6-D1B 2.06 2 1 s 
1.63 4/6 2 s 
2.72 5 1 s 
2.54 1/3 2 s Commercial 
InsP 2.30 2 1 s 6
1.75 4/6 2 s 
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Table 7.  13C chemical shift assignments of F2-S1-Q6-D1B and commercial InsP . 6
 
 
 
 
 
 
13C  
Carbon 
Position 
 Chemical 
Shift 
Integration Multiplicity
77.40 5 1 s 
75.89 4/6 2 s F2-S1- 
Q6-D1B 74.51 2 1 s 
73.39 1/3 2 s 
77.47 5 1 s 
75.77 4/6 2 s Commercial 
InsP 74.72 2 1 s 6
73.38 1/3 2 s 
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Figure 30. 1H NMR spectra of F2-S1-Q6-D1B and InsP6 standard at pH 8.22. 
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Figure 31. 31P NMR spectra of F2-S1-Q6-D1B and InsP6 standard at pH 8.04. 
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Figure 32. 13C NMR spectra of F2-S1-Q6-D1B and InsP6 standard at pH 8.04. 
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InsP6 has six phosphomonoester groups attached to the inositol ring, and 
possesses six strong acid sites with pKa ~1.8, two moderately weak acid sites with pKa 
~6.3, one weak acid site with pKa ~8.6, and three least acidic protons with pKa values of 
9.2 to 9.6 (Barre et al., 1954; Isbrandt and Oertel, 1980).  Initial NMR spectra of the 
commercial InsP6 obtained from sodium phytate with its pH adjusted to 8.45 did not 
match very well with the spectra of F2-S1-Q6-D1B.  Furthermore, 31P NMR spectra are 
extremely sensitive to pH and various factors such as temperature, pH meter error and 
equilibration time can affect pH readings during measurement, although later commercial 
InsP6 was adjusted to the same pH value as that of F2-S1-Q6-D1B.  Therefore, a series of 
1H (Figure 33) and 31P NMR (Figure 34) spectra were recorded over the pH range 8.0 – 
8.5 of the commercial InsP6.  The 1H NMR of the commercial InsP6 revealed that spectra 
are identical at pH 8.04, 8.13 and 8.22, whereas 1H resonances started shifting at pH 8.35.  
It is evident that the spectrum obtained from sodium phytate with its pH adjusted to 8.45 
exhibited downfield chemical shifts of all corresponding 1H resonances, most likely due 
to NaCl generated by dissociation of Na+ from sodium phytate via the addition of HCl 
(Malinowski et al., 1966).  31P NMR spectra changed drastically with different pH values, 
including both chemical shift and intensity ratios.  For example, at pH 8.13, only three 
31P resonances were observed at 3:1:2, whereas after an increase of only 0.09 pH unit, 
another 31P resonance appeared and the intensity ratio changed to 2:1:1:2.  In addition, 
31P resonances have a trend to shift downfield as the pH increases. 
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Figure 33. 1H NMR spectra of F2-S1-Q6-D1B and InsP6 standard at different pH over the 
range 8.0 -- 8.5. 
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Figure 34. 31P NMR spectra of F2-S1-Q6-D1B and InsP6 standard at different pH over 
the range 8.0 -- 8.5.  
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Two-dimensional NMR 
Two-dimensional 1H-31P HSQC, 1H-13C HSQC and 1H-1H COSY experiments 
were obtained for both F2-S1-Q6-D1B (Figures 35-37) and the commercial InsP6 
(Figures 38-40) to assign the chemical shifts as well as to compare the correlation 
patterns.  All 2-D NMR of F2-S1-Q6-D1B showed identical correlation patterns to those 
obtained from the commercial InsP6.  Consistency in correlation patterns, chemical shifts 
and intensity ratios in all 1-D and 2-D NMR spectra strongly confirm that the pure 
molecule from the active fraction F2-S1-Q6-D1B is InsP6.   
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Figure 35.  1 13H- C HSQC of F2-S1-Q6-D1B. 
 
  116
 
2
4/6
1/3
5
2
4/6
1/3
5
 
 
 
Figure 36.  1 1H- H COSY of F2-S1-Q6-D1B. 
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Figure 37.  1 31H- P HSQC of F2-S1-Q6-D1B. 
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Figure 38. 1 13H- C HSQC of InsP  standard. 6
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Figure 39.  1 1H- H COSY of InsP  standard. 6
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Figure 40.  1 31H- P HSQC of InsP  standard. 6
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Bioactivity of standard  
A bioassay was carried out to investigate whether the commercial InsP6 inhibits 
the early-stage somatic embryo growth, and whether there is a concentration response 
between this molecule and the bioactivity.  The F2-S1-Q6-D1B fraction used for 
recording the NMR spectra had a pH of 8.22.  InsP6 possesses six strong acid sites with 
pKa ~1.8, two moderately weak acid sites with pKa ~6.3, one weak acid site with pKa ~8.6, 
and three least acidic protons with pKa values of 9.2 to 9.6 (Barre et al., 1954; Isbrandt 
and Oertel, 1980).  Additionally, an array of sodium adduct ions were observed 
downstream of the InsP6 peak in the LC/MS analyses.  Therefore, the number of sodium 
cations associated with InsP6 in F2-S1-Q6-D1B was assumed as eight.  F2-S1-Q6-D1B 
corresponding to the extract from 100 FGs was previously weighed out at 0.11 mg (Table 
4).  Thus the mass of F2-S1-Q6-D1B was adjusted to 836 Da for the InsP6-8Na salt 
during the calculation of the number of moles.  F2-S1-Q6-D1B (20 FGs) was calculated 
to contain 26.3 nmoles of InsP6, which corresponds to 658.9 pmoles in half a FG.  
Therefore, the commercial phytic acid dodecasodium salt hydrate (12 Na+ attached) of 
26.3 nmoles was used as a concentration factor of 1.  A stock solution (0.53 mM) was 
made and concentration factors of 0.1, 0.2, 1 and 5 were generated by dilution (Table 8) 
and the bioassay was performed as described earlier. 
All treatments of the commercial InsP6 at four different concentrations inhibited 
the somatic embryo growth in a statistically significant manner (Figure 41).  Furthermore, 
inhibition from the treatment with concentration factor 1 was the most significant.  This 
result suggests a good correlation between the amount of InsP6 purified from FG tissue 
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(1.3 nmoles per stage 9 or full-term FG) and the amount of InsP6 inhibiting somatic 
embryo growth. 
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Table 8.  InsP  standard preparation for bioassay. 6
Concentration 
factor to  F2-
S1-Q6-D1B 
μg of dodecasodium 
phytate for each 
treatment 
μl of stock 
solution 
added 
pH (before 
adjustment) 
pH (after 
adjustment) 
5 121.6 250 7.52 5.71 
1 24.3 50 6.84 5.68 
0.2 4.9 10 6.51 5.71 
0.1 2.4 5 6.30 5.70 
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Figure 41.  Bioassay result of treatment of InsP6 standard with various concentrations. 
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Initial Characterizations as a Plant Peptide Hormone 
MALDI analysis of trypsin digest 
A small protein with a mass of 9607 Da was initially thought to be the inhibitory 
molecule present both in F2 and subfraction P3 from the Phenomenex Jupiter C5 column.  
Figure 42 shows the initial flow chart of separation and characterization of the inhibitory 
molecule.  P3 was reduced by TBP (tributylphosphine), alkylated by iodoacetamide, and 
trypsin digested in the presence of NH4HCO3 and HCl according to the protocol provided 
with the Sigma kit.  MALDI-TOF and TOF/TOF mass spectra of the resulting digest 
were acquired with the Applied Biosystems 4700 Proteomics Analyzer.   Peptide mass 
fingerprint (PMF) search against NCBInr database was performed using a Mascot search 
engine with the submission of both MS and MS/MS spectra.  The search was repeated 
with tryptic (both peptide ends tryptically cleaved) and semitryptic (one peptide end 
tryptically cleaved) cleavages.  MS/MS spectra with a Mascot score higher than the 
significant score of 95% were assumed to be correct calls.  Unfortunately, scores 
obtained from multiple peptide hits based on the P3 fraction were all below 80%, 
suggesting that no match was found in the database.   De novo sequencing was performed 
through distinguishing different fragment ions directly from individual MS/MS spectra 
without resorting to database sequence information.  However, too many peptide 
fragments made it impossible to assemble each complete polypeptide. 
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Figure 42.  Initial flow chart of separation and characterization of the inhibitory molecule. 
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Gel and capillary electrophoresis  
Gel electrophoresis (SDS-PAGE and Native-PAGE) was carried out to correlate 
with MS results.  Fractions (F1 through F4) from the Superdex 75 column and 
subfractions (P1 through P3) from the Phenomenex Jupiter C5 column were separated by 
SDS-PAGE and stained by Coomassie Blue on a PhastSystem (GE Healthcare, 
Piscataway, NJ).  Multiple protein bands were observed from the active fraction F2, and 
four distinct bands were labeled with arrows (Figure 43).  However, none of the 
subfractions from the Jupiter C5 column showed any distinct bands, and neither did 
subfractions from the Mono S column (data not shown), although LC/MS detected one 
distinct protein of 9607 Da in the P3 subfraction from the C5 column and several small 
peptides ranging from 2000 to 3000 Da in the F2-S1 subfraction from the Mono S 
column.  This lack of correlation between gel electrophoresis and MS indicated that the 
latter is significantly more sensitive than the former under such low concentrations of 
samples.  Therefore, this gel electrophoresis methodology was abandoned for 
characterization of subsequent active fractions. 
Capillary electrophoresis (CE) analyses including SDS-gel MW and IEF were 
performed on a Proteolab PA 800 (Beckman Coulter, Fullerton, CA), mainly for the 
investigation of new separation methodologies, but also for the correlation with MS 
results.  Due to the lack of ability to collect separated fractions, CE could only be used 
for the structure characterization.  Figure 44A shows the calibration electropherogram of 
the capillary (50 µmID × 57 cm length) using standards ranging from 10 to 225 kD.  
However, as shown in Figure 44B, most components in F2 and subfractions P1, P2, P3 
were below 10 kD, suggesting that this SDS-gel MW CE protocol is not applicable to the 
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structure elucidation of the inhibitor.  Therefore, this CE methodology was also 
abandoned for characterization of subsequent active fractions. 
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Figure 43.  SDS-PAGE of fractions from the Superdex 75 and the Phenomenex Jupiter 
C5 columns. 
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Figure 44. (A) Calibration electropherogram of the capillary (50 µmID × 57 cm length) 
using standards ranging from 10 to 225 kD; (B) electropherogram of CE separations of 
F2, P1, P2 and P3. 
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Separation and characterization of Stimulator 
The preliminary results of the stimulator project were obtained by Dr. Charlie 
Oldham in our lab.  Stage 2 or 3 FGs were water extracted and lyophilized to dryness.  
The lyophilized powder was subjected to 0.1% TFA precipitation.  The resulting 
supernatant was loaded on a C18 solid-phase extraction cartridge and the flow-through 
was collected and lyophilized.  The lyophilized product was separated by an Allsphere 
C8 HPLC column (4.6 × 250 mm, Alltech, Deerfield, IL) using acetonitrile as mobile 
phase A and potassium phosphate as mobile phase B.  After the stimulator project was 
taken over by me, a further separation protocol of the bioactive fraction from C8 was 
established.  An Allsphere semi-prep C18 HPLC column (10 ×  250 mm, Alltech, 
Deerfield, IL) was used with methanol as mobile phase A and water as B, both containing 
0.1% TFA, at a flow rate of 4.7 ml/min.  A 30-min gradient was applied: 3% A for 12 
min, 3% to 14% A over 13 min, 14% to 3% A for 5 min.  The subfraction eluting from 
3.7 to 4.5 min showed statistically significant inhibition to somatic embryo growth.  Thus 
the bioactive subfraction was analyzed by LC/MS.  Unlike the inhibitor which has 
multiple proteins present in the active fraction from the Superdex 75 column, the 
stimulator did not show any multiple charged state indicating peptides or proteins.  This 
suggested that the stimulator is a small molecule, not a plant peptide hormone.  Original 
flow chart of isolation and characterization of the stimulator is shown in Figure 45. 
This project was then taken over by Dr. Veronica DeSilva from this point.  She 
modified some of the isolation procedures by eliminating the C8 column and adding a 
Prevail C18 column (Waters, Milford, MA).  The stimulator was later characterized as 
citric acid by means of proton NMR and fast atom bombardment MS.  A good correlation 
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was found between the amount of citric acid isolated from the FG tissue (65 nmoles per 
stage 2-3 FG) and the amount of citric acid that stimulates colony growth (25 to 50 
nmoles) when applied topically to early-stage somatic embryos (DeSilva et al., 2007). 
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Figure 45.  Original flow chart of isolation and characterization of the stimulator.
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CHAPTER IV 
 
DISCUSSION 
 
Summary and importance of the discovery 
We present here the first report of isolation of myo-inositol hexakisphosphate 
(InsP6) from FG tissue in LP seeds.  The highly anionic InsP6 was purified by water 
extraction, two gel filtrations and two ion exchange FPLC chromatographies.  The results 
presented here also represent the first complete structural characterization of InsP6 from a 
natural product.  Identical exact mass and fragmentation patterns obtained from high 
resolution exact mass measurement and MS/MS analysis established that the purified 
compound from FG tissue is one of the isomers of inositol hexakisphosphate.  Direct 
structural identification of this FPLC purified inositol hexakisphosphate was then 
performed using 1H-, 31P- and 13C-NMR, 1H-1H COSY, 1H-31P HSQC and 1H-13C HSQC.  
The results unequivocally established that the molecule isolated from FG tissue is InsP6.    
We also report here the first evidence of inhibition of embryonic cell growth and 
development by InsP6 in LP.  SE in conifers is based on the natural occurrence of 
cleavage polyembryony in vivo.  This technology has been serving as a model to study 
early regulatory and morphogenetic events in higher plants (Zimmerman, 1993; Quiroz-
Figueroa et al., 2006; Imin et al., 2007).  An early-stage somatic embryo multiplication 
assay was used as a search for inhibitory activities.  This assay was also used recently to 
identify and isolate citric acid as a stimulator to growth of somatic embryos (DeSilva et 
al., 2007).  We demonstrated that topical application of commercial InsP6 to early-stage 
  134
somatic embryos indeed inhibits embryonic growth in a statistically significant manner.  
Furthermore, we found that there is a good correlation between the amount of InsP6 
purified from FG tissue (1.3 nmoles per full-term FG) and the amount of InsP6 which 
inhibits somatic embryo growth. 
InsP6 is ubiquitous and the most abundant inositol phosphate derivative in 
eukaryotic cells.  It is known for its anticancer activity by reducing the proliferation of 
malignant cells (Shamsuddin et al., 1992; Shamsuddin and Yang, 1995; Ferry et al., 
2002).  Additionally, InsP6 increases differentiation of malignant cells leading to 
reversion to the normal phenotype with decreasing production of tumor markers 
(Shamsuddin and Vucenik, 2005).  However, reduction of proliferation in plant cells has 
not been reported to date, and the real function of InsP6 in plants is still an enigma.  Our 
findings constitute the first observation of InsP6 inhibiting cell proliferation in plants. 
     
Purification and Identification of InsP6
Due to its six anionic phosphate groups, InsP6 has mainly been separated from 
other inositol phosphates using high-performance strong anion exchange chromatography 
(Skoglund et al., 1998; Talamond et al., 1998; Talamond et al., 2000; Carlsson et al., 
2001) or ion-pair HPLC with refractive index detection (Hamada, 2002).  The former 
technique can be performed using either of two chromatographic systems: one uses 
hydrochloric acid gradient elution with post-column reaction with a solution of iron 
nitrate and perchloric acid and UV detection at 295 nm (Chen and Li, 2003); the other 
uses a sodium hydroxide gradient with chemically suppressed conductivity detection 
(Talamond et al., 2000).  InsP6 purification from a parasitic cestode has also been 
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reported recently (Irigoin et al., 2002), in which InsP6 was detected in the hydatid cyst 
wall of the larval stage of the cestode parasite Echinococcus granulosus.  Purification 
was achieved by two sequential FPLC columns, a Source 15Q strong anion exchange 
column and a Superdex 75 gel filtration column (both from GE Healthcare).  Dialysis 
was carried out using a 12 kD cut-off membrane after the Source 15Q column and the 
inhibitory activity of in vitro complement-activation assay remained afterwards.  In 
addition, based on the calibration curve of Irigoin et al. using Superdex 75, InsP6 eluted 
with a mass of approximately 3 kD.  These results are in agreement with the results 
reported here, in that ultrafiltration against 3000 Da cut-off membrane after the Mini Q 
column for eight hours did not filter out InsP6 and bioactivity still remained in the 
embryo multiplication assay.   
Based on our calibration curve of the Superdex 75 column, the F2 fraction eluted 
in the mass range of 9kD to 16 kD.  This is because InsP6 can bind directly with charged 
groups of proteins or indirectly with the negatively charged groups of proteins mediated 
by a mineral cation such as K+, Mg2+, Ca2+, Mn2+ and Zn2+.  For example, InsP6 binds to 
nonvisual arrestins that desensitize G protein-coupled receptors, through interactions at 
the polar termini of Lys and Arg side chains.  This InsP6 binding regulates negatively 
interactions of arrestin with plasma membrane and nuclear signaling proteins by 
promoting arrestin cytosolic oligomerization (Milano et al., 2006).  InsP6 was also 
reported to form soybean protein-phytate-mineral complexes, which reduces 
bioavailability of minerals as well as protein digestibility and functionality (Honig and 
Wolf, 1991).  In addition, negatively charged amino acid groups of alkaline phytase from 
Bacillus provides a favorable electrostatic environment for its substrate Ca2+-InsP6 (Ha et 
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al., 2000; Oh et al., 2006).  An InsP6-binding protein with a KD of 14 nM was isolated 
from detergent-solubilized rat brain membranes by means of an InsP4 affinity column.  
SDS-PAGE analysis of this protein revealed that it comprises three subunits at 115, 105 
and 50 kD.  Photoaffinity experiments indicated that both 115- and 105-kD subunits 
possess recognition sites for InsP6, whereas the 50-kD subunit lacks a specific 
recognition site (Theibert et al., 1992).  Thus, multiple proteins or peptides in the mass 
range of 9kD to 16 kD co-eluted with InsP6 via binding.  This result was also supported 
by the detection of various proteins in LC/MS spectra of both F2 and F2-S1 fractions.   
One step of strong cation exchange chromatography was included before the 
anion exchange in the final protocol.  Since F2-S1 eluted before the salt gradient started, 
in retrospect, this step may not be necessary.  However, it did remove significant amount 
of components including proteins from the F2 fraction and those components might not 
have been easily separated from two subsequent columns.   
Inhibition to embryo growth was observed in both F2-S1-Q5 and F2-S1-Q6 
fractions, but neither of them showed inhibition as significant as that of the F2-S1 control.  
There were two possibilities for the decrease in activity: the total amount of InsP6 was 
divided between F2-S1-Q5 and F2-S1-Q6, since the ion at m/z 661 was observed in both 
fractions from LC/MS; a minor percentage of InsP6 might have lost during ultrafiltration 
against water.  The former contributed mainly to the activity decrease, in that InsP6 
behaves in dialysis at low ionic strength as if it had a higher molecular mass than 
predicted from its formula due to the high charge to mass ratio and the hydrogen bonding 
between phosphate groups of InsP6 (Van der Kaay and Van Haastert, 1995; Hanakahi et 
al., 2000; Irigoin et al., 2002).  This also explained why there was no significant 
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difference in yield of F2 and F2-S1 using either 1000 Da or 3000 Da cutoff ultrafiltration 
membranes.   
The Superdex Peptide column was selected for the optimized desalting procedure 
to increase the yield as well as to remove plasticizer contaminants in F2-S1-Q6 detected 
from MS.  The final active fraction, F2-S1-Q6-D1B, had no significant absorbance at 
three different wavelengths (215, 254, 280 nm), indicating a lack of aromatic amino acids, 
purine or pyrimidine moieties (Hanakahi et al., 2000).  This result was not surprising in 
that InsP6 has no appreciable UV absorbance at these wavelengths and could only be 
detected at 295 nm via post-column reaction (Chen and Li, 2003). 
 
Mass Spectrometry Characterization 
The fact that the (M+H)+ ion at m/z 661 is consistently present through four 
successive active fractions indicate that the corresponding molecule is indeed from the 
FG tissue through the sequential fractionation and not produced from the purification 
process.  The purity measured by means of LC/ESI-MS of the final active fraction F2-S1-
Q6-D1B indicated that the active molecule is homogeneous and has an average mass of 
660 Da.  Exact mass measurement of F2-S1-Q6-D1B under negative polarity exhibited 
identical exact mass to the calculated molecular mass of InsP6.  Subsequent tandem MS 
analyses of both F2-S1-Q6-D1B and the commercial InsP6 showed identical MS/MS 
spectra under both collision energies of 40 and 80 eV.  All these results suggest that the 
pure inhibitory molecule is InsP6 or one of its isomers.  
When active fractions were approaching purity, they lost ability to bind to the C8 
reversed phase capillary column in contrast to F2 and F2-S1 fractions, mainly because 
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there are no proteins available to react directly or indirectly with the phosphate groups on 
InsP6.  One alternative HPLC methodology for LC/MS, ion-pair chromatography, 
coupled to a double focusing inductively coupled plasma-sector field-mass spectrometry 
(ICP-SF-MS) was developed recently for the determination of InsP6 and its degradation 
products (InsP1 – InsP5) (Helfrich and Bettmer, 2004).  A C18 reversed phase column 
was used; eluent A was water and eluent B consisted of 10% (w/w) methanol, 20 mmol/L 
citrate and 0.04% (w/w) tetrabutylammonium hydroxide as the ion-pair reagent.  The 
HPLC separation of the six phosphorus species was achieved in a 15-min gradient elution.  
However, no LC/ESI-MS of InsP6 has been presented so far. 
Although the error tolerance for the exact mass measurement under positive 
polarity was set at ±30 ppm, the empirical formula C6H18O24P6 corresponding to InsP6 
was not included in the candidate list.  F2-S1-Q6 exhibited exact mass (M+H)+ of 
660.8479 with an error of negative 31.5 ppm with respect to the calculated molecular 
mass of InsP6 at 660.8687.  This huge error could only be caused by inaccurate 
calibration.  However, with the lack of a candidate empirical formula, it was not possible 
to evaluate the calibration.   
The LC/MS/MS spectrum under positive mode of F2-S1-Q6 at a collision energy 
of 40 eV was identical to those obtained at 30 and 35 eV as presented by Hsu et al. (Hsu 
et al., 2003).  A series of prominent ions at m/z 643, 625, 607, 581, 563, 545, 527, 483, 
465, 447, 429, 385, 367, 349, 287, 269, 259, 189, 179, 161, 99 were generated by 
successive losses of H2O (18 amu), HPO3 (80 amu), or H3PO4 (98 amu) from the 
precursor ion at m/z 661.  Some fragment ions arose from multiple pathways, as 
described in early results.  A further MS of the product ions was performed at m/z 563, 
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545 and 483 to elucidate the multiple pathways for the formation of ion at m/z 465.  
Additionally, they found that further loss of CO from ions at m/z 287, 269, 207, and 109 
generated ions at m/z 259, 241, 179, 81, respectively, which resembled those observed for 
inositol at m/z 109 and 81.  The latter result was supported by the product-ion spectrum 
of the m/z 109 ion.  The presence of m/z 81 ion (HPO3 + H) + in the product-ion spectrum 
of m/z 99 (H3PO4 + H)+ confirmed that ion at m/z 81 arose from a water loss from ion at 
m/z 99.   
 
NMR Characterization 
The InsP6 standard solution used for MS analyses was in an initial attempt as the 
NMR standard.  However, several unknown peaks showed in 1H, 31P and 13C 1-D spectra, 
suggesting that the InsP6 solution was not pure.  Hamada (Hamada, 2002) reported that 
the commercial 40% or 50% phytic acid solution contains substantial amounts of its 
degradation products such as InsP3, InsP4 and InsP5, which suggested that those unknown 
peaks were from the lower inositol phosphates.  Thus a pure InsP6 standard was needed 
for NMR spectra recording to compare with those from F2-S1-Q6-D1B.  Phytic acid 
dodecasodium salt hydrate (98% pure, recrystallized) with twelve acidic protons replaced 
by sodium cations, has also been used as InsP6 standard (Hamada, 2002; Chen and Li, 
2003).  
Since tandem MS results revealed that fragmentation pattern of F2-S1-Q6-D1B 
was identical to that of the commercial InsP6, one can conclude that the purified 
compound is InsP6, or one of its eight isomers.  Figure 46 shows the nine stereoisomeric 
inositol hexakisphosphate, including myo-, neo-, L-chiro, D-chiro, allo-, scyllo-, epi-, cis- 
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and muco-inositol hexakisphosphate.  However, no complete NMR studies have been 
published for the other eight stereoisomeric inositol hexakisphosphate.  Hypothesis of the 
identity of the stereoisomeric inositol hexakisphosphate was based on 13C NMR spectra 
of InsP6 (Isbrandt and Oertel, 1980), neo-, L-chiro, D-chiro, allo-, scyllo-inositol 
hexakisphosphate, epi-inositol (Podeschwa et al., 2003), and cis- and muco-inositol 
(Takahashi et al., 2001).  InsP6 showed four distinct 13C peaks with an intensity ratio of 
1:2:1:2 below pH 9.2.  neo-inositol hexakisphosphate possessed two 13C peaks at 74.24 
and 76.57 ppm with an intensity ratio of 2:1. Both L-chiro- and D-chiro-inositol 
hexakisphosphate showed three 13C peaks at 72.9, 73.3 and 76.5 ppm with an intensity 
ratio of 1:1:1.  allo-inositol hexakisphosphate had three distinct 13C peaks at 71.13, 72.30 
and 75.40 ppm.  scyllo- inositol hexakisphosphate, on the other hand, exhibited only one 
13C peak.  Since no 13C NMR spectra are available for epi-, cis- and muco- inositol 
hexakisphosphate in literature and 13C NMR spectra are not as pH dependent as 1H and 
31P NMR spectra, 13C NMR spectra of epi-, cis- and muco- inositol were used as the 
reference.  Both cis- and muco-inositols have two 13C peaks.  epi-inositol also showed 
four distinct 13C peaks as myo-inositol at 69.07, 72.29, 73.99 and 76.70 ppm, but the 
intensity ratio of epi-inositol (1:1:2:2) was different from that of myo-inositol.   
Based on all these available information, only myo- and epi- inositol 
hexakisphosphate were possible candidates, in that both InsP6 and epi-inositol showed 
four 13C peaks, the same number of 13C peaks observed in F2-S1-Q6-D1B.  The intensity 
ratio of 1:2:1:2 from F2-S1-Q6-D1B is in agreement with that from InsP6.  Moreover, no 
literature regarding epi-inositol hexakisphosphate has been reported and epi-inositol is 
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nonexistent in nature (Vitelio et al., 2004).  Taken together, InsP6 is hypothesized to be 
the inhibitory molecule. 
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Figure 46. Stereoisomeric inositol hexakisphosphate.  
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Spectra were initially recorded at room temperature, but no peak splitting was 
detected.  After the probe temperature was decreased to 7 oC, an evident splitting pattern 
was exhibited by H1/3, H5 and H4/6.  This result is in agreement with that of Bauman et al 
(Bauman et al., 1999), who reported previously that the coalescence temperature, Tc, for 
H1/3, H5 and H4/6 was 15 oC at pH 9.3.   Barrietos et al. reported that 1H NMR spectra of 
InsP6 are very pH dependent (Barrietos and Murthy, 1996), in that below pH 9.2, InsP6 
exists in the sterically-unhindered 1ax/5eq form (Figure 47), above pH 9.5 in the 
sterically-hindered 5ax/1eq form, whereas between pH 9.2 and 9.5, both forms are at 
equilibrium.  Although all NMR spectra obtained from the commercial InsP6 presented 
here were in the sterically stable 1ax/5eq form, initial NMR spectra at pH 1.6 and 2.6 
(data not shown) showed dramatically different 1-D and 2-D spectra from those obtained 
over the pH range 8.0 – 8.5.  Spectra at pH 1.6 and 2.6 are identical, showing three 1H 
peaks at 1:2:3, four 31P peaks at 1:2:2:1, four 13C peaks at 1:2:1:2, all different chemical 
shifts in 1-D NMR spectra and different correlation patterns in 2-D NMR from those 
obtained over the pH range 8.0 – 8.5.  1H, 31P and 13C spectra at various pH values are 
consistent with those of Barrietos and Isbrandt (Isbrandt and Oertel, 1980; Barrietos and 
Murthy, 1996). 
The broader 31P peaks from F2-S1-Q6-D1B relative to those from the commercial 
InsP6 resulted mainly from approximately 20 fold higher concentration of the commercial 
InsP6, and partially from paramagnetic ions such as Fe and Mn from the FG extract 
(Pullman et al., 2003b) involved in F2-S1-Q6-D1B causing sharp peaks to overlap 
(McDowell and Stewart, 2005). 
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Although the multiplicity of H2 as doublet in F2-S1-Q6-D1B is not as evident as 
that in the commercial InsP6, the peak width of both is identical.  This unapparent doublet 
in F2-S1-Q6-D1B might be caused by substantial amounts of InsP6-salt precipitates 
formed during several rounds of deuterium oxide dissolution and lyophilization, whereas 
the commercial InsP6 did not undergo these processes.  The InsP6-salt precipitates are 
easy to form aggregates which cause peaks broader and unapparent split pattern. 
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Figure 47.  Two conformations of InsP . 6
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Scale-up collection and concentration-dependent bioactivity 
The inhibitory bioactivity of same amount of FG from full-term dry seeds was 
lower than that from stage 9.10-9.12 seeds, resulting from the degradation of InsP6 from 
mechanical drying process (Pullman and Buchanan, 2003).  The InsP6 concentration-
dependence of the inhibitory activity was investigated.  A good correlation was observed 
between the amount of InsP6 purified from FG tissue (1.3 nmoles per full-term FG) and 
the amount of InsP6 inhibiting somatic embryo growth.  However, this amount of InsP6 
purified from FG tissue is an underestimation of the actual content of InsP6 in full-term 
FG, in that phosphorus in InsP6 present in FG tissue of full-term white spruce seeds 
weighs 12.0 μg per FG, corresponding to 64.7 nmoles of InsP6 per full-term FG (Reid et 
al., 1999).  Although InsP6 has never been characterized in LP, both LP and white spruce 
are conifers and InsP6 levels in both full-term FG tissues should be similar.   
Since InsP6 can bind to hydrophobic proteins which are not water soluble, water 
extraction of FG would lose some InsP6.  Plus, only certain percentage of analyte would 
be recovered from each column chromatography and ultrafiltration, these steps would 
also contribute some loss of InsP6.  Additionally, the total amount of InsP6 was divided 
between F2-S1-Q5 and F2-S1-Q6, and only F2-S1-Q6 was purified further for the final 
collection.  The unique 11-step purification processes established here involved multiple 
sample transfers, which would inevitably lose InsP6 in between.  Hence, heat drying of 
seeds, water extraction of FG, successive FPLC purification and ultrafiltration, and 
inevitable sample transfer would explain the substantial loss of InsP6 from its initial 
amount in FG tissue.   
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Proposed mechanism of inhibition 
Can inhibition of somatic embryo growth by InsP6 in plants share the same 
mechanism as some cancer cells in animals?  InsP6 has been known for its anticancer 
activity since the late 1980s.  Reduction of the elevated rate of malignant cell 
proliferation to normal level has been observed both in vivo and in vitro in a dose- and 
time-dependent manner (Shamsuddin and Vucenik, 2005).  Cells from different origins 
have different sensitivity to InsP6, indicating that the mechanism of InsP6 anticancer 
action varies in cell types.  Although the cellular mechanisms behind the anticancer 
activity have been known for a while to involve cell proliferation and differentiation, 
there is still no clear agreement about the biochemical pathways (Shamsuddin and 
Vucenik, 2005).   
InsP6 has been found to impair epidermal growth factor- or phorbol ester (tumor 
promoter)-induced JB6 (a well-characterized cell culture model for studying tumor 
promotion) cell transformation and activator protein 1 activation.  This impairment 
results from the block of epidermal growth factor-induced phosphatidylinositol-3 kinase 
(PtdIns 3-kinase) activity (Huang et al., 1997).  Additionally, the structure of InsP6 is 
similar to D-3-deoxy-3-fluoro-ptdIns, a potent PtdIns 3-kinase inhibitor (Powis et al., 
1995).  It is likely that InsP6 can inhibit PtdIns 3-kinase in plants. 
There are four families of PtdIns 3-kinases based on sequence homology and their 
preferred inositol lipid substrate(s).  Only the PtdIns-specific Vps34p-related 3-kinase 
family has been found in all the eukaryotic cells.  This kinase family phosphorylates only 
PtdIns at the D3-positon of the inositol ring, and is not able to phosphorylate PtdIns 4-
monophosphate or PtdIns 4,5-bisphosphate.  In mammals and yeast, PtdIns 3-kinases are 
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involved in mitogenesis, apoptosis, trafficking of membrane proteins, membrane ruffling, 
glucose uptake, chemotaxis, the oxidative burst response in neutrophils, and activation of 
intracellular signaling molecules such as rac, ras, rab, MAP kinase, protein kinase B/Akt, 
protein kinase C and JNK/p38 kinase (Munnik et al., 1998; Leevers et al., 1999; Meijer 
and Munnik, 2003).   
Several PtdIns 3-kinase homologues have been cloned in plant species including 
soybean (Hong and Verma, 1994), Arabidopsis thaliana (Welters et al., 1994) and 
Brassica napus (Das et al., 2005).  In Arabidopsis thaliana, the PtdIns 3-kinase AtVPS34, 
has a significantly higher homology to yeast VPS34 than to the mammalian PtdIns 3-
kinase (p110).  Expression of antisense AtVPS34 mRNA results in severe inhibition in 
growth and development of second-generation transformed plants.  This lethal phenotype 
indicates that PtdIns 3-kinase also plays an important role in plant development and 
growth.  The authors hypothesized that plant PtdIns 3-kinase is associated with vesicle 
transport of proteins to the vacuole.  Recently, both PtdIns 3-kinase and PtdIns 4 -kinase 
activities have been observed during the induction of somatic embryogenesis in coffea 
arabica (Ek-Ramos et al., 2003).  Products of both kinases, PtdIns 3- monophosphate and 
PtdIns 4-monophosphate, were detected in the somatic-embryo extracts of two early 
stages, cells without differentiated structures and the first differentiated stage.  When 
wortmannin (an inhibitor to both PtdIns 3-kinase and PtdIns 4-kinase) was added to these 
two early-stage extracts, wortmannin suppressed the formation of both PtdIns 3- 
monophosphate and PtdIns 4-monophosphate in a dose-dependent manner.  Furthermore, 
growth of somatic embryos was inhibited by wortmannin included in the induction 
medium during the first differentiated stage.  
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Although several molecular mechanisms can be suggested for the observed 
inhibition of early-stage somatic embryo multiplication by InsP6, we hypothesize that 
InsP6 exerts this role via the inhibition to PtdIns 3-kinase.  Nevertheless, another possible 
cause, the block of access of minerals from medium for embryos to imbibe, can not be 
completely ruled out. 
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Proposed function in vivo of InsP6
The function of InsP6 in plants, except for the storage of phosphorus in seeds, is 
still at an early stage of investigation.   InsP6 accumulates in a linear fashion throughout 
seed development and degrades to lower-phosphate inositol phosphates during 
germination (Strother, 1980; Raboy and Dickinson, 1987).  Abscisic acid (ABA), the 
plant drought-stress hormone, induces stomatal closure, conserving water and ensuring 
plant survival.  Recently, Lemtiri-Chlieh et al. reported that ABA elevates InsP6 levels, 
and InsP6 inactivates the plasma membrane K+-inward conductance which is a well 
characterized target of ABA response, in a cytosolic calcium-dependent manner in 
Solanum tuberosum stomatal guard cells (Lemtiri-Chlieh et al., 2000).  InsP6 also 
functions as an endomembrane-acting calcium release signal (Lemtiri-Chlieh et al., 2003).  
These findings suggest that InsP6 is a downstream component of the ABA signaling 
pathway.   
Seed dormancy is a temporary failure or block of a viable seed to germinate under 
physical conditions that are otherwise favorable for its germination.  Germination 
initiates with the uptake of water by imbibition by the dry seed, followed by embryo 
expansion (Finch-Savage and Leubner-Metzger, 2006).  When storage compounds 
accumulate during seed maturation, water content decreases, ABA accumulates, and 
desiccation tolerance and primary dormancy are established.  Overexpression of genes 
involved in ABA anabolism increases seed ABA levels, enhances seed dormancy, and 
delays germination (Frey et al., 1999; Thompson et al., 2000; Lindgren et al., 2003; 
Nambara and Marion-Poll, 2003).  In contrast, ABA deficiency is associated with the 
absence of primary dormancy and the precocious germination of mature seeds.  ABA is 
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produced from the embryo and/or the maternal tissues during seed development.  
Reciprocal crosses and grafting experiments between wild-type and ABA-deficient 
mutants of Arabidopsis (Koornneef and Karssen, 1994; Nambara and Marion-Poll, 2003), 
tomato (Groot and Karssen, 1992; Hilhorst, 1995) and Nicotiana plumbaginifolia (Frey et 
al., 1999) revealed that only ABA produced by the embryo during seed development has 
the capacity to induce a lasting dormancy, whereas maternal ABA and exogenous ABA 
application during seed development fail to impose seed dormancy.  ABA inhibits the 
transition from water uptake (phases 1 and 2) during germination to water uptake during 
post-germination growth (phase 3) (Kucera et al., 2005).  Thus, ABA is a positive 
regulator of seed dormancy and downregulates seed germination. 
Gibberellin (GA), on the other hand, releases dormancy, promotes germination, 
and counteracts ABA effects.  Two other plant hormones, ethylene and brassinosteroid 
(BR), also counteract the inhibitory effects of ABA on seed germination.  However, they 
act after dormancy has been released by gibberellin in most species (Kucera et al., 2005).   
In seeds from temperate regions, dormancy is alleviated by a prolonged period of 
moist incubation at low temperatures (chilling or stratification).  Recent findings 
(Andriotis et al., 2005) revealed that chilling alleviates hazel seed embryo dormancy with 
an early response of InsP6 mobilization.  InsP6 levels in embryonic axes (the site where 
the block of germination is imposed) were reduced by 60% within the first three weeks at 
5 oC, which was not detected in warm-imbibed tissue.  Increased phytase activity was 
found during chilling.  These results indicate that InsP6 turnover to lower-phosphate 
inositol phosphates supports metabolic reactivation during dormancy alleviation and 
preparation for subsequent germination in hazel seeds. 
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Taken together, we hypothesize that the biological function of InsP6 in plants is 
the regulation of seed germination and dormancy release via the crosstalk of ABA and 
GA, ethylene or BR.  A complete description of this regulatory pathway is illustrated in 
Figure 48.  When seeds approach maturation in fall, drought increases endogenous ABA 
levels, and ABA in turn elevates its downstream component InsP6 and induces seed 
dormancy.  In the end of winter, chilling directly activates the hydrolysis of InsP6 to 
lower-phosphate inositol phosphates, or indirectly activates this hydrolysis via a signal 
hormone, such as GA, ethylene or BR.  The InsP6 turnover alleviates seed dormancy and 
induces germination.  
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Figure 48. Hypothesized pathway of InsP6 function in vivo.  When seeds approach 
maturation in fall, drought increases endogenous ABA levels, and ABA in turn elevates 
its downstream component InsP6 and induces seed dormancy (sap green route in 
horizontal orientation).  At the end of winter, chilling directly activates the hydrolysis of 
InsP6 to lower-phosphate inositol phosphates, or indirectly activates this hydrolysis via a 
signal hormone, such as GA, ethylene or BR.  The InsP6 turnover alleviates seed 
dormancy and induces germination (pink route in vertical orientation).  
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Impact of the discovery and future work 
We herein present the first discovery of InsP6 in FG of LP seeds and its inhibition 
to early-stage somatic embryo growth.  The biochemical and physiological mechanisms 
in regulating this process, and perhaps other processes in plants, remain to be determined.  
We hypothesize that InsP6 suppresses early-stage somatic embryo growth via the 
inhibition to PtdIns 3-kinase.  More experiments need to be carried out to prove this 
hypothesis.  First of all, the in vitro binding of InsP6 on PtdIns 3-kinase and inhibition of 
InsP6 to the PtdIns 3-kinase activity will be studied.  Second, the PtdIns 3-kinase cDNA 
as well as the PtdIns 3-kinase activity need to be identified in the early-stage somatic 
embryos of LP.   Third, the mechanism by which PtdIns 3-kinase regulates plant growth 
and development needs to be determined.  Understanding the inhibition mechanism of 
InsP6 would allow us to improve the SE technology by overcoming the current bottleneck, 
to elucidate enigmatic functions of InsP6 in plants, and most importantly, to utilize this 
molecule properly.   
The biological function of InsP6 such as seed dormancy and germination remains 
to be answered.  We hypothesize that InsP6 participates in the crosstalk between the plant 
hormones ABA and GA/ethylene/BR to regulate seed dormancy and germination in 
response to environmental changes.  If this hypothesis is true, monitoring lower-
phosphate inositol phosphates is essential.  Additionally, it would be intriguing to 
discover the signaling transduction pathway involving both InsP6 and Ins(1,4,5)P3 in the 
germination process.   
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